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Chapter 1
Introduction
The aim of this study is to contribute to the understanding of the effect of 
the multiple sclerosis (MS) on health-related quality of life (HRQoL). MS 
is a chronic neurological disease with an unpredictable course, making 
it a very subjective and case specific disease. The emphasis in this thesis 
is put on psychological and social factors that have shown to play an 
important role on quality of life in various health conditions, but so far not 
in MS [1-8]. This chapter covers the theoretical background of the thesis, 
describes the aims and the theoretical model used for the study, presents 
the research questions and outlines the structure of this thesis.
1.1 Multiple sclerosis
Multiple sclerosis (MS) is the most common neurological disease with 
disabling consequences that occurs in young adults, more often affecting 
women than men [9]. It is a chronic disease characterised by diffuse changes 
in the white and grey matter, the breakdown of myelin and damage to 
axons within the central nervous system (CNS) [10]. Globally, the median 
estimated prevalence of MS was 30 patients per 100,000 people in the year 
2008 and increased to 33 per 100,000 in 2013 with the highest prevalence in 
high income countries [9,11]. The prevalence of MS varies around the world 
with the highest prevalence being in Europe and North America (108 and 
140 per 100,000 respectively) and with the lowest prevalence occurring in 
the Sub-Saharan Africa and East Asia (2.1 and 2.2 per 100,000). Latitude 
also seems to be a factor in prevalence of MS where proximity to equator 
correlates with lower risk of developing MS.  The average onset of MS is 
30 years and the duration of this disease can last for many decades. 85% 
of the new patients are diagnosed with relapsing-remitting MS which 
is characterized by acute attacks of worsening symptoms followed by a 
recovery phase. The duration of these attacks is individual and can last 
from days to months. In this type of MS, the disease does not worsen in 
the periods between the attacks. 80% of patients who are diagnosed with 
the relapsing-remitting type of MS later develop a secondary-progressive 
type of the disease. 10% of the patients are initially diagnosed with 
primary-progressive MS which is characterized by a gradual but steady 
progression of disability. Relapses and remissions are not present in this 
type. 5% of the patients are diagnosed with the progressive-relapsing 
type of MS which has a steady progression of disability and also acute 
attacks that may or may not be followed by recovery [9,12].
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Some of the most prevalent symptoms of MS are sensory problems 
(occurring in 40% of the MS population), problems with movement and 
transportation (occurring in 39% of the MS population) and fatigue 
(occurring frequently, but the more severe form can be found in 30% of the 
MS population) [9]. These disabling symptoms pose multiple challenges 
for both physical and psychological well-being [13] and have a negative 
impact on a patient’s health related quality of life (HRQoL) [14], which is 
an area in need of more research focused on it [9]. Symptoms of MS and 
their effects are reflected in the disability that can be quantified using the 
Expanded Disability Status Scale (EDSS). It assesses various functional 
systems (pyramidal, cerebellar, brainstem, sensory, bowel and bladder, 
visual, cerebral and other) and assigns to patients a functional system 
score based on their disability [15,16].
The most widely used criteria for the diagnosis of MS are the 
McDonald criteria that underwent revisions since their implementation 
and now include magnetic resonance imaging (MRI), which demonstrates 
multiple areas of involvement and also involvement over time with 
the appearance of new enhancing lesions [17,18]. Advanced MRI and 
spectroscopy may allow clinicians to follow the pathological progression 
of the disease and to monitor the response to the treatment [19]. MS 
patients frequently suffer from depressive symptoms, which impact their 
HRQol and can even lead to suicidal ideations [20]. Other psychological 
symptoms most often associated with multiple sclerosis include anxiety 
[21], cognitive impairment [22] and fatigue [23].
1.2 Health related Quality of Life
The diagnosis of MS brings with it a serious risk of worsening patient‘s 
HRQoL and previous research in this field supports this notion [24]. 
Domains of HRQoL affected by MS include the physical, mental and 
social domains. Most of the symptoms resulting from MS are responsible 
for the decreased quality of life in the physical domain like pain, sensory 
problems, fatigue, movement impairments and bowel and bladder issues 
[25]. The mental domain of quality of life is mostly impaired by various 
symptoms of depression, anxiety and fatigue [26]. Depression especially 
is a very prominent factor influencing quality of life and even when 
physical symptoms are not very limiting, in combination with depression, 
levels of HRQoL can be very low [27]. Depending on the phase in which 
the patient currently is, mental symptoms can have various forms. In the 
initial progression of the disease high levels of anxiety can lead to neurotic 
problems, which can get even higher during attacks. In remissions, 
depressive symptoms can take root because of the uncertain onset of the 
next attack. Cognitive impairment in any stage of MS can lead to low 
levels of self-worth and self-esteem [28]. MS can also affect the social 
domain of HRQoL with negative impacts on work patterns which can 
lead to problems with co-workers or unemployment [29], it can cause 
psychosexual problems and consequently dyadic issues and problems in 
relationships [30] and social participation can be impaired as well, with 
patients unable to engage in social activities as much as their peers [31].
1.3 Coping self-efficacy
Coping is defined as the effort to manage a stressful situation and involves 
various cognitive and behavioural efforts to overcome external or internal 
demands which are appraised as either taxing or exceeding the person´s 
resources [32]. To manage a stressful situation, various coping strategies 
can be used. Problem-focused coping encompasses all strategies that 
try to actively eliminate threatening factors or actively try to diminish 
the impact of such factors [33]. Emotion focused coping implements 
strategies such as searching for social support, understanding from other 
people and positive emotions from other people [34]. Coping focused on 
stopping unpleasant emotions and thoughts is, as the name of this type 
suggests, focused on avoiding unpleasant factors associated with stressful 
situation. Although avoidant tendencies were generally perceived as 
maladaptive, this type of coping can have a positive effect in situations 
when the individual does not have the resources to eliminate the problem 
directly or a solution is not possible [35]. Problem-focused and emotion-
focused coping can easily occur simultaneously. Emotion-focused coping 
can even facilitate problem-focused coping by removing some of the 
distress that can hamper problem-focused efforts; similarly, problem-
focused coping can render the threat less forbidding, thereby diminishing 
distress emotions [33].
Problem-focused coping was found to contribute positively to the 
health-related quality of life (HRQoL) of patients with various chronic 
conditions. The positive effect of coping can appear either in the mental 
health component of HRQoL only [36], or in both the mental and physical 
components [37]. Folkman and Lazarus state that men use more problem-
focused coping than women at work and in situations requiring acceptance 
and requiring more information [38]. Increasing age is usually associated 
with a decline in the use of both problem-focused and emotion-focused 
coping strategies [39].
Self-efficacy is a construct describing some one’s personal belief 
about one’s ability to perform certain behaviour successfully with the 
expected outcome [40]. Research on self-efficacy in the MS context has 
mostly focused on aspects related to physical activity and exercise, such 
as beliefs about performing activities of daily living, autonomy issues, 
movement and work [41-44]. Other studies focused on the association 
between self-efficacy and fatigue and depression but the psychological 
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aspects of self-efficacy such as coping were not prominent in the research 
[45,46].
1.4 Type D personality and Self-esteem
MS negatively affects the patient’s HRQoL, and influences various 
psychological resources such as the concept of self and self-esteem and 
even plays a role in modification of personality through depression 
and anxiety, which are frequent symptoms of MS [47]. On the other 
hand, previous research also indicates that depression and anxiety are 
more important for HRQoL than personality [48,49]. Depression and 
depressive symptoms along with anxiety are closely intertwined with 
Type D personality which can be described as a personality where 
negative affectivity and social inhibition play a large role in daily 
activities. Focusing on the negative side of things coupled with inhibition 
of behaviour and emotional responses during social interaction can 
subsequently influence mental and social aspects of HRQoL [50]. Another 
deeply integrated personality variable is self-esteem which results from 
a personal self-view and is prone to change over time [51]. Self-esteem 
is easily modified by depressive symptoms [52], especially in a situation 
of chronic illness and can change some one’s outlook on self-worth, self-
efficacy and lead to low levels of mental HRQoL [53].
1.5 Social participation
The presence of a disease or disorder was until recently considered as 
satisfactory prerequisites for various decisions in the caretaking process 
of patients with chronic conditions. The main source of these decisions 
was the International Statistical Classification of Diseases and Related 
Health Problems (ICD-10), which classifies them. In 2002 the scientific 
approach and research operationalization underwent a significant shift by 
introducing the World Health Organization’s International Classification 
of Functioning, Disability and Health (ICF) (Figure 1.1). 
 
Figure 1.1 The International Classification of Functioning, Disability and Health
This classification is complementary to the ICD-10 because where 
the ICD-10 classifies causes of death, the ICF classifies functioning and 
disability associated with health conditions. Key terms for the ICF model 
are impairment, activity and participation, where participation is the key 
construct that has been included to replace the term handicap [54].
Participation is defined by the ICF as involvement in life situations 
[54] and can be affected by impairments and activity limitations interacting 
with environmental and personal factors [55]. A subcategory of overall 
participation is social participation which is closely linked to self-esteem, 
life satisfaction and mental health status, making it a very important 
factor for Health Related Quality of Life (HRQoL) [56,57]. This makes 
the ICF a truly biopsychosocial model combining physical, psychological 
and social aspects of HRQoL all together and providing a more complete 
picture of health in all its facets. The social aspect of HRQoL, engagement 
with community activities, friendships and meaningful volunteer work 
are perceived as strategies for maintaining social participation, especially 
for people suffering from a chronic disease [58]. Social participation is 
also a subjective variable in which the same level of social participation 
may be satisfactory for one person, but it may be too low for another. The 
peer concept of comparison is thus an important factor to get an objective 
assessment of this variable.
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1.6 aim of the thesis and its research questions
This thesis aims to provide insights in the associations between physical 
and psychosocial factors and health related quality of life in patients with 
multiple sclerosis. It builds on previous studies describing psychosocial 
factors in health impaired populations [59-61] and also adds research 
questions to previous studies focusing on multiple sclerosis [62]. 
Because of its multidimensional nature both physical and psychological 
variables were studied in association with HRQoL. By associating 
sociodemographic variables, functional disability, disease duration, 
coping, social participation, fatigue, type D personality and self-esteem 
with HRQoL we tried to answer the following research questions (Figure 
1.2).
Figure 1.2 Design of the variables used in the study 
Research question 1 
Are different coping strategies associated with different levels of health 
related quality of life? (Chapter 3)  
Research question 2
Is social participation associated with the physical and mental components 
of quality of life? (Chapter 4)
Research question 3
Do different coping strategies mediate the association between fatigue 
and health-related quality of life? (Chapter 5)
Research question 4
Do different coping strategies mediate the association between type D 
personality and health related quality of life? (Chapter 6)
Research question 5
What is the effect of self-esteem on the association between social 
participation and health related quality of life? (Chapter 7)
1.7 outline of the thesis
This thesis is divided into eight chapters.
Chapter 1: “Introduction“ provides the basic background about multiple 
sclerosis and focuses on the importance of psychological and social 
resources of patients with multiple sclerosis for their HRQoL. Furthermore, 
the theoretical model and five research questions are formulated.
Chapter 2: “Data sources“ provides information about the design of the 
study. It describes the data collection and the study sample used in this 
thesis. It also provides a short description of the measures and analyses 
used.
Chapter 3: “Coping and its importance for Quality of Life in patients with 
multiple sclerosis“ explores the association between three coping strategies 
and health-related quality of life in patients with MS.
Chapter 4: “Social participation and Health-Related Quality of Life in people 
with multiple sclerosis“ describes social functioning of patients with MS 
and their social participation and its links with health-related quality of 
life.
Chapter 5: “Can coping make you less tired? The mediating effect of coping on 
the association between fatigue and Quality of Life in patients with multiple 
sclerosis“ elaborates on the association between fatigue and health-related 
quality of life and how it can be mediated by coping.
Chapter 6: “Do coping strategies mediate the association between Type D 
personality and Quality of Life among patients with multiple sclerosis“ analyses 
the association between Type D personality and health-related quality of 
life and how this it is mediated by different coping strategies.
Chapter 7: “Self-esteem, social participation and their asociation with Quality 
of Life in patients with multiple sclerosis“ explores whether self-esteem 
encourages social participation and association of these two variables 
with health-related quality of life.
Chapter 8: “General discussion, implications and conclusions“ presents and 
discusses the main findings of this thesis as well as its strenghts and 
limitations and its implications for practice and further research.
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This chapter provides a general overview of the origin of the data, 
measures and statistical analyses used in this thesis.
2.1 Study design, population and data collection
The study design of this thesis was cross-sectional. The data were collected 
between September 2010 and June 2013 in the Department of Neurology 
of the Louis Pasteur University Hospital in Košice, covering the catchment 
area of Eastern Slovakia which covers 1,570,000 people. Two hundred and 
fourteen patients with multiple sclerosis (MS) who met inclusion criteria 
were asked to participate in the study. 58 patients (60.3% women) refused 
to participate resulting in response rate of 72.9%. Exclusion criteria 
were applied to the rest of the sample. They consisted of the presence of 
a psychiatric diagnosis, the score on the Mini-Mental State Examination 
(MMSE) <24, pregnancy and the inability to speak Slovak. Based on 
these criteria, no additional patients were excluded from the study. The 
final sample (N=156) had a median age of 403± years and consisted of 
75.0% women. There were no statistically significant differences between 
participants and non-participants regarding age or gender. The process of 
sample formation is depicted in Figure 2.1.
Figure 2.1 Process of sample formation
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Filling in the self-report questionnaires, a semi-structured interview 
and neurological examination were the parts of the data collection. The 
invitation letter, the informed consent form, the non-response sheet and 
the questionnaires were sent to participants› homes by postal mail. Two 
weeks later, patients were reminded about the questionnaires by a phone 
call, and their neurological examination and interview were scheduled 
at the same time. The neurological examination and the interview 
were performed at the Department of Neurology of the Louis Pasteur 
University Hospital in Košice. The neurological examination was carried 
by the same neurologist, and a trained interviewer conducted the semi-
structured interview.
2.2 Measures
Health-related quality of life
Health-Related Quality of Life (HRQoL) was assessed using the 36-item 
Short-Form (SF-36) health survey [1]. The SF-36 includes multi-item 
scales to measure 8 dimensions: 1. physical functioning (ten items), 2. role 
limitation due to physical health (four items), 3. bodily pain (two items), 
4. social functioning (two items), 5. general mental health (five items), 6. 
psychological distress and well-being (five items), 7. role limitations due 
to emotional problems (three items), 8. vitality, energy or fatigue (four 
items). All item scores are coded and transformed into a scale of 0 (poor 
health) to 100 (optimal health). SF-36 also provides researchers with 
possibility to calculate the Physical Component Summary (PCS) and the 
Mental Component Summary (MCS). Both component summaries are 
calculated from four scales of SF-36. In both dimensions, higher score 
indicates better HRQoL. In our sample Cronbach’s alpha for PCS was 0.92 
and for MCS 0.93.
Coping self-efficacy
Coping self-efficacy was measured using the 26-item Coping Self-Efficacy 
Scale (CSE) developed specifically for chronically ill populations [2]. 
Coping self-efficacy is a prerequisite for using actual coping strategies as 
patients need to be sure, they can perform coping actions before they act 
upon them. Patients were asked to answer the following question: ‘When 
things are not going well for you, or when you’re having problems, how 
confident or certain are you that you can do the following’. They then 
had to indicate the extent to which they believe they could perform each 
coping behaviour on an 11-point scale. The instrument consists of three 
subscales representing self-efficacy for the use of problem-focused coping 
strategies (ranging from 0-120), the ability to stop unpleasant emotions 
and thoughts (ranging from 0-90), and finally the ability to get support 
from friends and family (ranging from 0-50). A higher score indicates 
a higher ability to cope with the situation described in the question. In 
our sample Cronbach’s alpha for three subscales was 0.94, 0.86 and 0.93 
respectively.
Social participation 
Social participation was measured by the Participation scale (P-scale), 
which includes 18 items and was developed for people with chronic 
conditions [3]. Each item consists of two questions. The first question goes 
into some aspect of social participation in comparison with one’s peers, 
for example: ”Are you as socially active as your peers are?” If participants 
answer “Yes” or “Irrelevant/I don’t want to, I don’t have to” their answer 
is scored 0. If the answer is “Sometimes” or “No”, the next question is: 
“How big a problem is this for you?” Participants then choose from four 
options: “No problem”, “Small”, “Medium” or “Large” which are scored 
1, 2, 3 or 5 respectively. The summary score can range from 0 to 90, with 
a higher score indicating more restriction in social participation. The 
authors arbitrary created, based on the score, five categories of restrictions 
in social participation: no restrictions (close to 40% of the data below raw 
score of 12), mild restrictions (close to 55% of the data below raw score of 
22), moderate restrictions (close to 70% of the data below raw score of 32), 
severe restrictions (close to 85% of the data below raw score of 52) and 
extreme restrictions (less than 15% of the data of the authors) [3]. In our 
study participation was treated as a continuous variable. In our sample 
Cronbach’s alpha for the p-scale was 0.89.
Fatigue
Fatigue was assessed by Multidimensional Fatigue Inventory (MFI) [4], 
which is commonly applied in patients with chronic conditions [5,6]. 
It consists of 5 dimensions: general fatigue (4 items), physical fatigue 
(4 items), mental fatigue (4 items), reduced motivation (4 items), and 
reduced activity (4 items). Patients were asked to share how much they 
agree with statements like: “I feel fit”, “I feel very active” or “Physically 
I feel only able to do a little” on a 5-point scale anchored in quotes: “Yes, 
that is true” and “No, that is not true”, where higher score indicated 
more prevalent fatigue in all 5 subscales. 10 of the items are worded in a 
negative way to prevent tendencies towards the response set, and scores 
for these items and for five categories were calculated accordingly. In our 
sample Cronbach’s alpha for the five subscales was 0.79, 0.84, 0.81, 0.64 
and 0.78 respectively.
Type D
To assess type D personality and its presence in our sample, the DS-14 
with its two constituent subscales of negative affectivity (NA) and social 
inhibition (SI) was used. NA stands for tendency to experience negative 
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emotions such as anger, irritability, hostility and anxiety. SI scale covers 
discomfort in social interactions, lack of social confidence, reticence and 
is more passive component of type D personality [7]. Patients rated these 
aspects of their personality on a 5-point Likert scale ranging from 0 (false) 
to 4 (true). Both scales range from 0 to 28 and type D is assigned when 
subject filling in the questionnaire scores ≥10 on both scales [7]. In our 
sample Cronbach’s alpha for type D was 0.89.
Self-esteem
Self-esteem in our sample was measured by the Rosenberg Self-Esteem 
Scale (RSE) [8]. It consists of 10 items assessing global self-esteem [9]. 
Examples of items include: “On the whole, I am satisfied with myself”, or 
“At times I think I am no good at all”. Five items are worded negatively 
and 5 positively in order to avoid the response set, which undergo 
recoding during analysis. The score ranges from 10 to 40 with a higher 
number indicating a higher level of self-esteem. In our study self-esteem 
was treated as a continuous variable. In our sample Cronbach’s alpha for 
the RSE was 0.87.
2.3 Statistical analyses
Several statistical methods were used across this study to analyse the 
data. All analyses were performed using statistical software package SPSS 
(version IBM SPSS 20), Medgraph and Mplus 7.1. Descriptive statistics 
were used for analysing the basic demographic, medical and psychological 
characteristics of participants. Multiple linear regression analyses (enter 
method) were used in chapters 3 and 4 to assess the variance of HRQoL 
explained by the studied variables and additionally in chapters 5-7 for 
data preparation, which then underwent further statistical analyses. 
The Sobel z-test was used to calculate the mediating effect of coping 
on the association between fatigue and Type D personality respectively 
associations with HRQoL in chapters 5 and 6. Finally, structural equation 
modelling was utilized to calculate the effect of self-esteem on the 
association between social participation and HRQoL.
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Chapter 3
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The aim of this study was to analyse whether problem-focused coping, 
coping focused on getting support and coping focused on stopping 
unpleasant emotions and thoughts are associated with different levels of 
physical and mental quality of life (PCS, MCS), controlling for gender, age 
and disease severity among MS patients.
Method
The sample consisted of 113 consecutive MS patients (response rate: 
79.6%; 77.0% women; mean age 40.8±9.2). Patients completed the Short-
Form Health Survey (SF-36) and the Coping Self-Efficacy Scale (CSE). 
Disability was assessed by Expanded Disability Status Scale (EDSS). The 
associations between CSE and PCS and MCS were analysed using linear 
regression.
Results
EDSS and age were significantly associated only with PCS. The regression 
model for problem-focused coping, coping focused on getting support 
and coping focused on stopping unpleasant emotions and thoughts 
explained 29%, 24% and 35% of the variance in MCS respectively. In PCS 
coping was not significant. 
Conclusions
Coping is significantly associated with MCS, but not with PCS. Stopping 
unpleasant emotions and thoughts seems to be the most important 
type of coping in MS patients. Thus, patients, their caregivers and 
their physicians should be educated about this type of coping and its 
positive association with MCS.
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Introduction
Multiple Sclerosis (MS) is the most common neurological disease that 
occurs in young adults with disabling consequences, more often affecting 
women than men. It is a chronic disease characterised by diffuse changes 
in the white and grey matter, the breakdown of myelin and damage to 
axons within the central nervous system (CNS) [1]. Its various symptoms 
can occur anywhere in the CNS and include fatigue, pain, loss of function 
or sensitivity in the limbs, dizziness and loss of balance, loss of bowel 
or bladder control, sexual dysfunction and a variety of cognitive and 
emotional changes. These disabling symptoms pose multiple challenges 
for both physical and psychological well-being [2] and have a negative 
impact on a patient‘s quality of life [3].
  The symptoms and limitations associated with MS cause high 
levels of distress which patients need to cope with. Coping is defined as an 
effort to manage a situation and involves various cognitive and behavioural 
efforts to overcome external or internal demands which are appraised as 
either taxing or exceeding the person´s resources [4]. To manage the stress 
caused by MS, patients can use, for example, problem-focused coping, 
which can be described as an effort to remove a threatening event or to 
diminish its impact. There is also coping focused on getting support, 
which can be described as an effort to reduce the negative feelings that 
arise in response to a threat or as seeking emotional support. Another way 
of coping with stress is to stop or avoid unpleasant thoughts about the 
problem in order to stop or prevent negative emotions. Problem-focused 
and emotion-focused coping can easily occur simultaneously. Emotion-
focused coping can even facilitate problem-focused coping by removing 
some of the distress that can hamper problem-focused efforts; similarly, 
problem-focused coping can render the threat less forbidding, thereby 
diminishing distress emotions [5]. Problem-focused coping was found 
to contribute positively to the health-related quality of life (HRQoL) of 
patients with various conditions. The positive effect of coping can appear 
either in the mental health component of HRQoL only [6], or in both the 
physical and mental components (PCS, MCS) [7]. Men use more problem-
focused coping than women at work and in situations requiring acceptance 
and requiring more information [8]. Increasing age is usually associated 
with a decline in the use of both problem-focused and emotion-focused 
coping strategies [9].
MS influences a person´s life for a very long time. For a patient it is 
vital that HRQoL should be improved by all means possible, including the 
most suitable way of coping. Thus far, little research has been done among 
MS patients regarding the association between coping and HRQoL. The 
studies that have been carried out on this topic are different from ours. 
Some of the studies dealing with the association between coping and 
HRQoL in MS patients have a significantly lower number of participants 
[10-12] or focused on women only [13]. Some of them use variables that 
are only partly responsible for overall HRQoL such as fatigue [14], coping 
in dyadic relationships [15] or focusing only on positive effect of problem-
focused coping [16]. However there is no study addressing all these three 
types of coping at once so this study tries to put another piece of the 
puzzle into the overall picture of this field of research. Thus, the aim of 
this study is to explore whether problem-focused coping, coping focused 
on getting emotional support and coping focused on stopping unpleasant 
emotions and thoughts are associated with PCS and MCS, controlling for 
gender, age and disease severity.
Methods
Participants
Out of 157 consecutive MS patients from neurology outpatient clinics 
in the eastern part of Slovakia, 32 (21 women and 11 men) refused to 
participate in the study (response rate 79.6%). Patients who met the 
McDonald criteria were eligible for the study [17]. Exclusion criteria 
were psychiatric diagnosis, Mini-Mental State Examination (MMSE) <24, 
pregnancy, diagnosis of Clinically Isolated Syndrome (CIS) [18], and the 
inability to speak Slovak. Based on these criteria 12 patients were excluded 
from the study. The final sample (N=113) consisted of 77.0% women and 
23.0% men, with a mean age of 40.8±9.2 years (range 20-59 years). 
Procedure
The data collection took place between September 2010 and May 2012. This 
cross-sectional study consisted of a self-reported questionnaire, a semi-
structured interview and a neurological examination. The invitation 
letter, the informed consent form, the non-response sheet and the 
questionnaires were sent to participants’ homes by postal mail. Patients 
were reminded about the questionnaires by a phone call two weeks later. 
During this phone call their interview and neurological examination was 
scheduled as well. These then took place at the Neurology Outpatient 
Clinic. One neurologist carried out the neurological examination and a 
trained interviewer conducted the semi-structured interview.
The Ethics Committee of the Medical faculty of PJ Safarik University 
approved the study before it started. Each patient provided a signed 
informed consent form prior to the study. 
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Measures
All questionnaires used in this study were translated from original 
language. Next, backwards translation was made to ensure that meaning 
was not lost in translation. Final changes in translated version were made 
accordingly.
Health-related quality of life
HRQOL was assessed using the 36-item Short-Form (SF-36) health survey 
[19]. The SF-36 includes multi-item scales to measure 8 dimensions: 1. 
physical functioning (ten items), 2. role limitation due to physical health 
(four items), 3. bodily pain (two items), 4. social functioning (two items), 
5. general mental health (five items), 6. psychological distress and well-
being (five items), 7. role limitations due to emotional problems (three 
items), 8. vitality, energy or fatigue (four items). In addition, one question 
covers changes in health status over the past year (one item). All item 
scores are coded and transformed into a scale of 0 (poor health) to 100 
(optimal health). PCS and MCS summaries were calculated. A higher 
score indicates better health in both dimensions. Cronbach’s alpha was 
0.91 for the PCS and 0.93 for the MCS for our sample. 
Coping self-efficacy
Coping self-efficacy was measured using the 26-item Coping Self-Efficacy 
Scale (CSE) developed specifically for chronically ill populations [20]. 
Coping self-efficacy is prerequisite for using actual coping strategies as 
patients need to be sure, they can perform coping actions before they act 
upon them. That is why in this article we treat terms coping and coping 
self-efficacy as equivalent because in our opinion, those concepts are 
closely tied to each other.
Patients were asked respond to the following question: ‘When 
things are not going well for you, or when you’re having problems, how 
confident or certain are you that you can do the following’. They then had 
to give the extent to which they believe they could perform each coping 
behaviour on an 11-point scale. The instrument consists of three subscales 
representing self-efficacy for the use of problem-focused coping strategies 
(ranging from 0-120), the ability to stop unpleasant emotions and thoughts 
(ranging from 0-90), and finally the ability to get support from friends and 
family (ranging from 0-50). A higher score indicates a higher ability to 
cope with the situation described in the question. Cronbach’s alpha was 
0.94 for problem-focused coping in the sample, 0.85 for coping focused on 
getting support and 0.93 for stopping unpleasant emotions and thoughts 
for our sample.
Clinical variables
We used medical records to obtain information on EDSS (score ranges 
from 0.0 to 10.0, with a higher score indicating more severe disability) [21] 
and the course of MS. Patients were categorized in the relapse-remitting 
(RRMS) course of MS or the secondary-progressive (SPMS) course of 
MS [22]. Data on sociodemographic variables were retrieved from the 
interview. 
Statistical analyses
Firstly, descriptive analyses of the study variables were carried out. 
Next, multiple linear regression analysis (the enter method) was used to 
examine the relationship between the three coping strategies and both 
PCS and MCS. The associations between the variables were controlled 
for gender, age and EDSS. These demographic and neurological variables 
were assessed as independent variables along with the three mentioned 
coping strategies, the effect of which was observed on the dependent 
variables (PCS, MCS). Statistical analyses were performed in IBM SPSS 20.
results
A basic description of the study population is given in Table 3.1 (N=113). 
The MS respondents averaged 40.8±9.2 years old and consisted of 77.0% 
women. The mean EDSS score was 3.3±1.3, with a mean disease duration 
of 8.4±6.7 years. The majority of the patients (84.9%) belonged to relapse-
remitting clinical course (Table 3.1).
Table 3.1 Characteristics of the study population 
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Table	  3.1	  Characteristi 	   f	  t 	  study	  population	  	  
Variables	   N	  (%)	   Mean	   SD	   Range	  
Age	  (years)	   109	   40.08	   9.26	   20-­‐59	  
Gender	   	   	   	   	  
	  	  	  male	   24(22%)	   	   	   	  
	  	  	  female	   85(78%)	   	   	   	  
Disease	  duration	  
(years)	  
	   7.79	   6.58	   1-­‐28	  
MS	  form	   	   	   	   	  
	  	  	  	  CIS	   10(9.2%)	   	  	  	  	  	   	   	  
	  	  	  	  RRMS	   84(77.1%)	   	   	   	  
	  	  	  	  SPMS	   15(13.7%)	   	   	   	  
EDSS	   	   3.18	   1.36	   1.0-­‐8.0	  
Coping	   	   	   	   	  
	  	  	  problem-­‐focused	   	   77.82	   22.98	   22-­‐120	  
	  	  	  getting	  support	   	   32.89	   10.11	   3-­‐50	  
	  	  	  stop	  emotions	  and	  
	  	  	  thoughts	  
	   57.10	   19.60	   4-­‐90	  
Quality	  of	  life	   	   	   	   	  
	  	  	  PCS	   	   37.25	   11.28	   16.0-­‐60.0	  
	  	  	  MCS	   	   43.23	   12.33	   17.3-­‐69.8	  
CIS	  –	  clinically	  isolated	  syndrome;	  RRMS	  –	  relapsing	  remitting	  multiple	  sclerosis;	  SPMS	  –	  secondary	  progressive	  multiple	  
sclerosis;	  EDSS	  –	  expanded	  disability	  status	  scale;	  PCS	  –	  physical	  component	  summary;	  MCS	  –	  mental	  component	  summary	  	  
	  
Linear	  regression	  analyses	  (Table	  3.2)	  were	  used	  to	  examine	  the	  associations	  between	  coping	  strategies	  
and	  PCS	  and	  MCS,	  controlled	  for	  gender,	  age	  and	  EDSS.	  The	  outcomes	  of	  the	  multiple	  linear	  regressions	  
indicate	  that	  all	  three	  types	  of	  coping	  are	  associated	  with	  MCS,	  but	  not	  with	  PCS.	  In	  PCS,	  EDSS	  explained	  
the	  most	  variance	  in	  the	  model	  regardless	  of	  which	  type	  of	  coping	  was	  analysed.	  Also,	  all	  three	  types	  of	  
coping	  showed	  a	  similar	  explanation	  of	  variance	   in	  their	  respective	  models.	  There	  were	  no	  differences	  
between	   coping	   focused	  on	   stopping	  unpleasant	   emotions	   and	   thoughts	   and	  problem-­‐focused	   coping	  
focused	   on	   getting	   support	   in	   terms	   of	   significance,	   but	   in	   the	   MCS,	   coping	   focused	   on	   stopping	  
unpleasant	  emotions	  and	  thoughts	  explained	  most	  of	  the	  variance	  in	  the	  model	  (Table	  3.2).	  	  
	  
	   	  
CIS – clinically isolate  yndrome; rrMS – relapsing remitting multiple sclerosis;  
SPMS – secondary progressive multiple sclerosis; eDSS – expanded disability status scale;  
PCS – physical component summary; MCS – mental component summary 
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Linear regression analyses (Table 3.2) were used to examine the associations 
between coping strategies and PCS and MCS, controlled for gender, age 
and EDSS. The outcomes of the multiple linear regressions indicate that 
all three types of coping are associated with MCS, but not with PCS. In 
PCS, EDSS explained the most variance in the model regardless of which 
type of coping was analysed. Also, all three types of coping showed a 
similar explanation of variance in their respective models. There were no 
differences between coping focused on stopping unpleasant emotions 
and thoughts and problem-focused coping focused on getting support 
in terms of significance, but in the MCS, coping focused on stopping 
unpleasant emotions and thoughts explained most of the variance in the 
model (Table 3.2). 
Table 3.2 Multiple linear regression (enter method) between the three coping styles and the PCS 
and MCS dimensions of the SF-36 controlled for age, gender and eDSS 
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Table	  3.2:	  Multiple	  linear	  regressi n	  (enter	   ethod)	  between	  the	  three	  coping	  styles	  and	  the	  PCS	  and	  
MCS	  dimensions	  of	  the	  SF-­‐36	  controlled	  for	  age,	  gender	  and	  EDSS	  	  
	   PCS	   MCS	  
	   Beta	   F	  Change	  
Adjusted	  
R2	  
Beta	   F	  Change	  
Adjusted	  
R2	  
Model	  1	   	   11.94*	   0.18	   	   0.36	   -­‐0.01	  
Age	   -­‐0.41*	   	   	   -­‐0.07	   	   	  
Gender	   -­‐	  0.09	   	   	   0.05	   	   	  
Model	  2	   	   23.27*	   0.40	   	   0.25	   -­‐0.02	  
Age	   -­‐0.17	   	   	   -­‐0.06	   	   	  
Gender	   0.04	   	   	   0.06	   	   	  
EDSS	   -­‐0.56*	   	   	   -­‐0.02	   	   	  
Model	  3	  A	   	   18.12*	   0.40	   	   11.65*	   0.30	  
Age	   -­‐0.15	   	   	   0.01	   	   	  
Gender	   0.02	   	   	   -­‐0.05	   	   	  




0.11	   	   	   0.58*	   	   	  
Model	  3	  B	   	   18.81*	   0.41	   	   9.20*	   0.24	  
Age	   -­‐0.15	   	   	   0.04	   	   	  
Gender	   0.04	   	   	   0.00	   	   	  
EDSS	   -­‐0.57*	   	   	   -­‐0.05	   	   	  
Getting	  
support	  
-­‐0.07	   	   	   0.53*	   	   	  
Model	  3	  C	   	   18.15*	   0.40	   	   15.00*	   0.36	  
Age	   -­‐0.16	   	   	   -­‐0.00	   	   	  
Gender	   0.04	   	   	   0.03	   	   	  





-­‐0.11	   	   	   0.62*	   	   	  
R2	  –	  explained	  variance;	  Gender	  -­‐	  male	  gender	  was	  set	  as	  reference;	  EDSS	  –	  expanded	  disability	  status	  scale;	  *p<.05	  
	  
Discussion	  
The	   aim	   of	   this	   study	   was	   to	   explore	   whether	   problem-­‐focused	   coping,	   coping	   focused	   on	   getting	  
emotional	  support	  and	  coping	  focused	  on	  stopping	  unpleasant	  emotions	  and	  thoughts	  were	  associated	  
with	  different	  levels	  of	  physical	  and	  mental	  quality	  of	  life	  when	  controlling	  for	  demographic	  and	  clinical	  
data	   in	  patients	  with	  MS.	  Our	   results	  provided	  evidence	   that	  all	   types	  of	   coping	  were	  associated	  with	  
r2 – explained variance; Gender - male gender was set as reference; eDSS – expanded disability 
status scale; *p<.05
Discussion
The aim of this study was to explore whether problem-focused coping, 
coping focused on getting emotional support and coping focused on 
stopping unpleasant emotions and thoughts were associated with 
different levels of physical and mental quality of life when controlling for 
demographic and clinical data in patients with MS. Our results provided 
evidence that all types of coping were associated with mental component 
of quality of life out of which stopping unpleasant emotions and thoughts 
was the most strongly associated with MCS. Regarding PCS coping was 
not significant, while EDSS showed the highest explanation of variance in 
this quality-of-life component.
The mental component of quality of life was for the most part 
determined in our models by coping. All three types of coping explained 
large portions of the overall variance in the mental component, and in 
contrast with the physical component, the disability (contribution of EDSS) 
was in this case not significant. In general, these results correspond with 
recent studies about the association of coping with the mental component 
of quality of life [6,23,24]. On the other hand, some studies dealing 
with chronic conditions have claimed that coping was not significantly 
associated with HRQoL at all [25] or even that coping focused on getting 
support is negatively associated with quality of life [26]; this is not in line 
with our findings.
Coping focused on stopping unpleasant emotions and thoughts in 
our sample explained the most variance of all the coping strategies in 
the mental component of quality of life. One possible explanation why 
stopping unpleasant emotions and thoughts might be adaptive as a 
coping strategy in patients with MS is that the patients have very little 
control over their disease. MS is in most patients a chronic progressive 
disease and no optimal cure has thus far been found. When patients lose 
the ability to control the disease and have to learn how to live with it, 
this kind of coping can help them to reduce the stress that MS brings and 
thus improve their mental quality of life. This interpretation is in line with 
previous works which suggest that this type of coping is more adaptive 
when little control is possible [27,28]. De Groot et al. also add that this 
type of coping seems to be more adaptive when patients have to cope with 
the emotional value of the problem [27]. 
On the other hand, our results showed that regarding the physical 
component of quality of life, the role of coping was not significant. It 
did not add to the explained variance of this variable, as EDSS did. This 
result is in line with existing studies dealing with coping and quality of 
life [6,23,29,30]. The reason why the physical component of quality of 
life was not associated with any type of coping might be the fact that 
residual persisting neurological symptoms cannot be suppressed by 
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coping strategies. Clinical neuropsychological symptoms appear even if 
patients use coping strategies effectively to deal with stress. The physical 
component of quality of life might be barely modified by psychological 
resources. 
Strengths and limitations
One of the strengths of this study is the high response rate within our 
sample (79.6%). Some limitations should be noted, however. Although the 
women–to-men ratio in MS is 2:1, in our sample the ratio was higher (77.0% 
women), so the results may better explain the quality of life of women 
than men. Also, patients with a lower disease severity (mean EDSS 3,2) 
were more likely to participate in the study, while patients with a more 
serious disability were more likely to refuse to participate. We expect the 
results would be even worse in the total MS patients group, although the 
high response rate might mitigate this effect.
Implications
This study is beneficial in bringing a new view on avoidance coping. 
Stopping unpleasant emotions and thoughts or not thinking about the 
disease showed in our results to be an adaptive and helpful for patients 
with MS. Although this type of coping may seem maladaptive, in our 
sample it helped to improve the mental component of quality of life. It is 
possible that this type of coping would also be adaptive in other patients 
with chronic conditions, but future research is needed to confirm this. 
The clinical importance of this study is that patients should consider 
using this type of coping in dealing with their condition. Physicians, 
caregivers and patients themselves should be educated about various 
ways of coping with their disease and encouraged to live a life without 
constant worries about their symptoms or the progress of their disease 
and thus improve their mental quality of life. MS clubs could apply these 
outcomes during discussions/educational programs with MS patients, 
where psychologists or trained caregivers could talk with patients about 
the various ways of coping with their disease. Physicians could also 
benefit from the knowledge about different ways of coping with stress, 
especially in the early stages of the disease when patients are still learning 
how to live with a new diagnosis of MS. Even patients with longer disease 
duration could make use of these findings if their coping strategies have 
so thus proved to be ineffective. These findings can also be implemented 
into the psychological therapy process. Cognitive Behavioural Therapy 
may especially work with stopping unpleasant emotions and thoughts in 
patients with MS [31].
Extreme usage of this coping strategy should not be encouraged 
though. Stopping unpleasant emotions and thoughts should not impact 
treatment adherence; therefore, education may focus on the long-term 
effects of the coping strategy used in situations where one’s behaviour 
cannot change the situation, and where treatment adherence requires a 
more active approach.
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abstract
Background
Social participation is an integral part of everyday life in society; however, 
evidence about its association with Health-Related Quality of Life 
(HRQoL) in people with multiple sclerosis (MS) is lacking. The aim of 
this study is to explore whether social participation is associated with the 
Physical Component Summary of HRQoL (PCS) and Mental Component 
Summary of HRQoL (MCS) in people with MS, controlled for age, gender, 
disease severity and disease duration.
Methods
The sample consisted of 116 consecutive people with MS (response rate: 
75.8%; 72.4% women; mean age 40.3±9.8). People with MS completed 
the Short-Form Health Survey (SF-36) for measuring PCS and MCS and 
the Participation Scale, which measures the level of social participation. 
Disability was assessed using the Expanded Disability Status Scale 
(EDSS). The associations between social participation, PCS and MCS, were 
analysed using linear regression that controlled for sociodemographic 
and clinical variables.
Results
PCS was significantly associated with age, disease duration, EDSS and 
social participation. MCS did not show significant association with the 
studied variables. Overall, a multiple regression model explained 48% of 
the PCS variance, while the proportion of MCS variance explained was 
not significant. 
38 CHaPTer 4 39
Conclusions
Social participation was significantly associated with PCS, suggesting a 
possibility for intervention in this domain.
Keywords: Multiple sclerosis, social participation, Health-Related Quality 
of Life
Introduction
Multiple Sclerosis (MS) is the most common neurological disease with 
disabling consequences in young adults. MS is a chronic progressive 
disease, with diffuse changes in the white and grey matter, the breakdown 
of myelin and damage to axons [1]. These changes are manifested in a 
wide range of symptoms, depending on the location of the process in 
the central nervous system (CNS). They may include immobility, loss of 
eyesight, loss of independence and problems in relationships or in sexual 
intimacy, with these symptoms having the worst impact on health-related 
quality of life (HRQoL) [2]. 
HRQoL is a multidimensional concept that includes an individual’s 
perception of the physical and mental components of HRQoL. In the 
case of MS, this concept is especially relevant, as the physical limitations 
inherent to the disease, such as the loss of personal independence, the 
loss of a job, fatigue, etc., are closely tied to social functioning as well. 
The physical and mental functioning of people with MS is decreased in 
comparison with the general population [3]. With the progression and 
longer duration of MS, neurological disability rises, causing in later stages 
not only physical, but also mental impairments [4]. 
Social participation is associated with HRQoL in people with 
disabilities [5-7]. Social participation is defined by the World Health 
Organization’s International Classification of Functioning, Disability 
and Health (ICF) as involvement in life situations [8]. It is affected by 
impairments and activity limitations interacting with environmental and 
personal factors [9]. Social participation is closely linked to self-esteem, 
life satisfaction and mental health status, which makes it a very important 
factor for HRQoL [10,11]. Engagement with community activities, 
friendships and meaningful volunteer work are perceived as strategies 
for maintaining social participation, especially for people with a chronic 
disease [12].
Thus far, little research has been conducted among people with MS 
regarding the association between their social participation and HRQoL. 
In some studies, social participation was measured merely as a part of 
the general quality of life concept [13]; only physical handicaps related 
to social participation were taken into account, including mobility [14] 
and communicative participation [15]. A number of studies have focused 
on the psychometric properties of the social participation measurement 
instruments [16-18] but not on the association between social participation 
and the actual HRQoL. Thus, the aim of this study is to explore the 
association of social participation with the physical and mental dimensions 
of HRQoL in people with MS, controlled for sociodemographic variables, 
disease duration and disease severity.
Methods
Participants
People who met the McDonald criteria (objective clinical findings, 
dissemination of specific lesions in the central nervous system and a 
paraclinical examination which helps to exclude false-positive and false-
negative diagnoses of MS) were eligible for the study [19]. A total of 153 
consecutive people with MS from the Neurology Department of the L. 
Pasteur University Hospital in Košice were asked to participate in the study. 
There was no selection based on age, gender or other variables. All people 
meeting the inclusion criteria (diagnosis of MS) who were scheduled for 
their regular neurological examination were asked to participate; 37 people 
(64.8% women and 35.2% men) refused to participate (a response rate of 
75.8%). Exclusion criteria were psychiatric diagnosis, a Mini-Mental State 
Examination (MMSE) score <24, pregnancy, the inability to speak Slovak 
and diagnosis of Clinically Isolated Syndrome [20]. Data collection took 
place between April 2011 and December 2012. There were no statistically 
significant differences between respondents and non-respondents in 
terms of gender or age.
Procedure
This cross-sectional study consisted of a self-reported questionnaire, 
a semi-structured interview and a neurological examination. The 
invitation letter, the written informed consent form, the non-response 
sheet and the questionnaires were sent to participants’ homes by postal 
mail. People in the study sample were reminded about the questionnaire 
by a phone call two weeks later. During this phone call, the interview and 
neurological examination were arranged. The same neurologist carried 
out the neurological examinations on all people and a trained interviewer 
conducted the semi-structured interview, acquiring information on 
age, gender, education and disease duration among other variables. 
Examinations took place at the Neurology outpatient clinic. 
The local Ethics Committee approved the study before it started. 
Each person provided a signed informed consent to participate prior to 
the study. 
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Measures
All questionnaires used in this study were translated from the original 
language. A back translation was then done to ensure that no meaning 
was lost in the translation. Final changes in the translated version were 
made accordingly.
Sociodemographic and clinical variables
Sociodemographic and clinical variables were retrieved from medical 
records and via the interview. During statistical analyses, the age of 
participants at the time of data collection was used. Besides disease 
duration (in years), EDSS (score ranges from 0.0 to 10.0 with higher score 
indicating more severe disability) and type of MS were retrieved from 
medical records, while information on age and education (elementary, 
high school and university) was gathered from the interview. People in 
the sample were diagnosed with the relapse-remitting (R-R) type of MS 
and the secondary-progressive (S-P) type of MS [21].
Social participation 
This variable was measured by the participation scale (p-scale), which 
includes 18 items and is intended for people with stigmatised conditions 
[22]. Each item consists of two questions. The first question goes into some 
aspect of social participation in comparison with one’s peers; for example: 
Do you take part in as many casual recreational/social activities as your 
peers?” If participants answer “Yes” or “Irrelevant\I don’t want to, I don’t 
have to” their answer is scored 0. If the answer is “Sometimes” or “No”, 
the next question is: “How big a problem is this for you?” Participants 
then choose from four options: “No problem”, “Small”, “Medium” or 
“Large”, which are scored as 1, 2, 3 or 5, respectively. The summary score 
can range from 0 to 90, with a higher score indicating more restriction 
and greater dissatisfaction with the amount of social participation. Based 
on the final score the authors also created five categories of restrictions 
in social participation: No restrictions (0-12), Mild restrictions (13-22), 
Moderate restrictions (23-33), Severe restrictions (34-53) and Extreme 
restrictions (54-90) [22]. We treated social participation as a continuous 
variable. Cronbach´s alpha for the p-scale in our sample was 0.88.
Health-related quality of life
HRQoL was assessed using the 36-item Short-Form (SF-36) health survey 
[23]. The SF-36 includes multi-item scales used to measure 8 dimensions: 
1. physical functioning (ten items), 2. role limitation due to physical health 
(four items), 3. bodily pain (two items), 4. general health (five items), 5. 
social functioning (two items), 6. psychological distress and well-being 
(five items), 7. role limitation due to emotional problems (three items), and 
8. vitality, energy or fatigue (four items). In addition, one question covers 
changes in health status over the past year (one item). All item scores are 
coded and transformed into a scale of 0 (poor health) to 100 (optimal health). 
The Physical Component Summary (PCS), which includes dimensions 
one through four (21 items), and the Mental Component Summary (MCS), 
which includes dimensions five through eight (14 items), were calculated 
and also range from 0 to 100, with a higher score indicating better health 
in both dimensions. In our study Cronbach´s alpha was 0.92 for the PCS 
and 0.93 for the MCS.
Statistical analyses
Firstly, descriptive analyses of the study variables were carried out 
(elementary and high school education were coded as dummy variables 
and university education was used as the reference category). Next, PCS 
and MCS were regressed on social participation and controlled for age, 
gender, education, disease duration and EDSS. Statistical analyses were 
performed in IBM SPSS 20.
results
A basic description of the study population is given in Table 4.1 (n=116). 
The respondents averaged 40.35 years old and consisted of 72.4% women. 
The mean EDSS score was 3.08, and the mean disease duration was 7.04 
years. The majority of people (79.2%) were diagnosed with the relapse-
remitting clinical type (Table 4.1).
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Table 4.1 Characteristics of the study population (N=116)
47	  
	  
Table	  4.1:	  Characteristics	  of	  the	  study	  population	  (N=116)	  
Variables	   N	  (%)	   Mean	   SD	   Range	  
Age	  (years)	   116	   40.35	   9.89	   18-­‐61	  
Gender	   	   	   	   	  
	  	  	  male	   32(27.6%)	   	   	   	  
	  	  	  female	   84(72.4%)	   	   	   	  
Education	   	   	   	   	  
	  	  	  elementary	   6(5.2%)	   	   	   	  
	  	  	  high	  school	   83(71.6%)	   	   	   	  
	  	  	  university	   26(22.4%)	   	   	   	  
Disease	  duration	  
(years)	  
	   7.04	   5.80	   1-­‐28	  
MS	  type	   	   	   	   	  
	  	  	  	  CIS	   8(9.7%)	   	  	  	  	  	   	   	  
	  	  	  	  RRMS	   65(79.2%)	   	   	   	  
	  	  	  	  SPMS	   9(10.9%)	   	   	   	  
EDSS	   	   3.08	   1.27	   1-­‐6.5	  
Participation	   116	   20.37	   18.07	   0-­‐60	  
	  	  	  1	   54(46.6%)	   	   	   	  
	  	  	  2	   15(12.9%)	   	   	   	  
	  	  	  3	   13(11.2%)	   	   	   	  
	  	  	  4	   25(21.6%)	   	   	   	  
	  	  	  5	   9(7.8%)	   	   	   	  
Quality	  of	  life	   	   	   	   	  
	  	  	  PCS	   116	   38.59	   11.25	   18.56-­‐60.0	  
	  	  	  MCS	   116	   42.91	   12.19	   18.88-­‐67.24	  
CIS	  –	  Clinically	  Isolated	  Syndrome;	  RRMS	  –	  Relapse-­‐Remitting	  Multiple	  Sclerosis;	  SPMS	  –	  Simple	  Progressive	  Multiple	  Sclerosis;	  
EDSS	  –	  Expanded	  Disability	  Status	  Scale;	  1	  –	  No	  restrictions;	  2	  –	  Mild	  restrictions;	  3	  –	  Moderate	  restrictions;	  4	  –	  Severe	  
restrictions;	  5	  –	  Extreme	  restrictions;	  PCS	  –	  Physical	  Component	  Summary;	  MCS	  –	  Mental	  Component	  Summary;	  
Missing	  values:	  EDSS:	  (23.2%),	  Education:	  (0.9%),	  Disease	  Duration:	  (12.9%),	  MS	  type:	  (29.3%),	  
Before	  we	  proceeded	  with	  the	  regressions,	  we	  prepared	  the	  data,	  starting	  with	  the	  correlations,	  
which	  indicated	  that	  EDSS	  correlated	  strongly	  with	  the	  sociodemographic	  data.	  PCS	  correlated	  with	  age,	  
EDSS	  and	  social	  participation,	  and	  MCS	  correlated	  only	  with	  social	  participation.	  The	  subscales	  of	  the	  SF-­‐
36	  did	  not	  correlate	  (Table	  4.2).	  
	   	  
CIS – Clinically Isolated Syndrome; rrMS – relapse-remitting Multiple Sclerosis;  
SPMS – Simple Progressive Multiple Sclerosis; eDSS – expanded Disability Status Scale; 1 – No 
restrictions; 2 – Mild restrictions; 3 – Moderate restrictions; 4 – Severe restrictions; 5 – extreme 
restrictions; PCS – Physical Compon nt Summary; MCS – Mental Compone t Summary;
Missing values: eDSS: (23.2%), education: (0.9%), Disease Duration: (12.9%), MS type: (29.3%)
Bef re we roceeded with he regressions, we prepared the data, 
starting with the correlations, which indicated that EDSS correlated 
strongly with the sociodemographic data. PCS correlated with age, 
EDSS and social participation, and MCS correlated only with social 
participation. The subscales of the SF-36 did not correlate (Table 4.2).
Table 4.2 Correlations between the variables under study
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Table	  4.2:	  Co relations	   n	  the	  variables	  under	  study	  
	   Age	   Gender	   Edu_elem	   Edu_HS	   EDSS	  
Disease	  
duration	  
Participation	   PCS	  
Age	   	   	   	   	   	   	   	   	  
Gender	   0.13	   	   	   	   	   	   	   	  
Edu_elem	   0.13	   0.11	   	   	   	   	   	   	  
Edu_HS	   -­‐0.01	   -­‐0.00	   -­‐0.40*	   	   	   	   	   	  
EDSS	   0.35*	   0.26*	   0.14	   0.03	   	   	   	   	  
Disease	  
duration	  
0.15	   -­‐0.04	   0.02	   0.00	   0.24*	   	   	   	  
Participation	   0.18	   0.12	   0.10	   0.17*	   0.25*	   0.26*	   	   	  
PCS	   -­‐0.43*	   -­‐0.11	   -­‐0.04	   -­‐0.10	   -­‐0.54*	   -­‐0.04	   -­‐0.57*	   	  
MCS	   0.02	   0.06	   0.02	   -­‐0.10	   0.09	   -­‐0.18	   -­‐0.27*	   0.03	  
Edu_elem	  –	  Elementary	  education;	  Edu_HS	  –	  High	  School	  education;	  EDSS	  –	  Expanded	  Disability	  Status	  Scale;	  PCS	  –	  Physical	  
Component	  Summary;	  MCS	  –	  Mental	  Component	  Summary; 
	  
In	   linear	   regression	   analyses	   (Table	   4.3)	   PCS	   and	   MCS	   were	   regressed	   on	   social	   participation	   and	  
controlled	   for	   age,	   gender,	   education,	   disease	   duration	   and	   EDSS.	   The	   outcomes	   of	   multiple	   linear	  
regression	  analyses	  indicate	  that	  social	  participation	  is	  an	  important	  factor	  associated	  with	  PCS,	  where	  
its	   statistically	   significant	   contribution	   added	   another	   14%	   to	   the	   previous	   model,	   so	   that	   the	   final	  
variance	  of	  the	  model	  was	  48%.	  EDSS	  and	  disease	  duration	  seem	  to	  be	  important	  only	  for	  PCS	  as	  well.	  In	  
MCS	  only	  the	  beta	  coefficient	  of	  social	  participation	  showed	  significance,	  but	  the	  overall	  variance	  of	  the	  
whole	  model	  was	  not	  significant.	  	  
	  
	   	  
edu_elem – elementary education; du_HS – High School education; eDSS – expanded Disability 
Status Scale; PCS – Physical Component Summary; MCS – Mental Component Summary;
In linear regression analyses (Table 4.3) PCS and MCS were regressed 
on social participation and controlled for age, gender, education, disease 
duration and EDSS. The outcomes of multiple linear regression analyses 
indicate that social participation is an important factor associated with 
PCS, where its statistically significant contribution added another 14% to 
the previous model, so that the final variance of the model was 48%. EDSS 
and disease duration seem to be important only for PCS as well. In MCS 
only the beta coefficient of social participation showed significance, but 
the overall variance of the whole model was not significant. 
Table 4.3 Multiple linear regression analyses (enter method): PCS and MCS regressed on social 
participation and controlled for age, gender, education, eDSS and disease duration
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Table	   4.3	   Multiple	   linear	   regression	   analyses	   (enter	   method):	   PCS	   and	   MCS	   regressed	   on	   social	  
participation	  and	  controlled	  for	  age,	  gender,	  education,	  EDSS	  and	  disease	  duration	  
	   PCS	   MCS	  












Model	  1	   	   	   5.80*/5.80*	   0.15	   	   	   0.48/0.48	   -­‐0.02	  
Age	   -­‐0.40*	   0.00*	   	   	   0.02	   0.78	   	   	  
Gender	   -­‐0.04	   0.61	   	   	   0.07	   0.46	   	   	  
Elementary	  
Education	  
-­‐0.03	   0.69	   	   	   -­‐0.03	   0.74	   	   	  
Secondary	  
Education	  
-­‐0.12	   0.21	   	   	   -­‐0.12	   0.25	   	   	  
Model	  2	   	   	   7.61*/14.14*	   0.34	   	   	   1.34/2.63	   0.02	  
Age	   -­‐0.21*	   0.03*	   	   	   -­‐0.10	   0.40	   	   	  
Gender	   0.09	   0.33	   	   	   0.07	   0.51	   	   	  
Elementary	  
Education	  
0.01	   0.87	   	   	   -­‐0.05	   0.62	   	   	  
Secondary	  
education	  
-­‐0.01	   0.90	   	   	   -­‐0.14	   0.26	   	   	  
EDSS	   -­‐0.56*	   0.00*	   	   	   0.17	   0.18	   	   	  
Disease	  
duration	  
0.14	   0.15	   	   	   -­‐0.25*	   0.03*	   	   	  
Model	  3	   	   	   11.12*/19.66*	   0.48	   	   	   2.01/5.53*	   0.08	  
Age	   -­‐0.16	   0.06	   	   	   -­‐0.06	   0.57	   	   	  
Gender	   0.08	   0.34	   	   	   0.06	   0.55	   	   	  
Elementary	  
Education	  
0.07	   0.42	   	   	   -­‐0.02	   0.86	   	   	  
Secondary	  
Education	  
0.08	   0.38	   	   	   -­‐0.07	   0.55	   	   	  
EDSS	   -­‐0.50*	   0.00*	   	   	   0.22	   0.08	   	   	  
Disease	  
duration	  
0.20*	   0.02*	   	   	   -­‐0.20	   0.08	   	   	  
Participation	   -­‐0.40*	   0.00*	   	   	   -­‐0.28*	   0.02*	   	   	  
R2	  –	  explained	  variance;	  Gender	  -­‐	  male	  gender	  was	  set	  as	  reference;	  Education	  –	  university	  education	  was	  set	  as	  reference;	  
EDSS	  –	  expanded	  disability	  status	  scale;	  *p<.05	  	  
	  
Discussion	  
The	  aim	  of	   this	  study	  was	  to	  determine	   if	   there	   is	  an	  association	  between	  social	  participation	  and	  the	  
physical	  and	  mental	  components	  of	  health-­‐related	  quality	  of	  life	  in	  people	  with	  MS.	  These	  associations	  
were	   controlled	   for	   demographic	   and	   clinical	   variables.	   Our	   results	   provide	   evidence	   that	   social	  
participation	  is	  an	  important	  factor	  associated	  with	  PCS,	  while	  in	  MCS	  it	  was	  not	  significant.	  
r2 – explained variance; Gender - male gender was set as reference; education – university 
education was set as reference; eDSS – expanded disability status scale; *p<.05 
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Discussion
The aim of this study was to determine if there is an association between 
social participation and the physical and mental components of health-
related quality of life in people with MS. These associations were 
controlled for demographic and clinical variables. Our results provide 
evidence that social participation is an important factor associated with 
PCS, while in MCS it was not significant.
According to our results, higher PCS scores are associated with higher 
levels of peoples’ satisfaction with the amount of social participation they 
engage in. A similar result was found on the other side of the scale, where 
low levels of social participation were associated with lower levels of PCS. 
In previous studies authors have suggested that the association between 
PCS and social participation is present because people with chronic 
diseases often experience some form of mobility impairment and thus 
consider their HRQoL to be better when they can still manage to integrate 
into the community compared with those whose social activity is low [14]. 
People with increased social participation can have a higher PCS because 
they are more involved in social life, or this involvement may result from 
the minimal obstacles in PCS, thus allowing for more social participation. 
Satisfaction with social participation, as a subjective variable, may 
reflect various physical and environmental factors that influence social 
participation [24]. Age, EDSS and disease duration showed a significant 
amount of variance in the final model, as expected, as they are closely tied 
to physical functioning and physical roles [25].
Our findings indicate that in MCS our proposed model is not 
significantly associated with this domain of quality of life, although the 
beta coefficient in social participation suggests that some weak association 
with social participation is present. But in interaction with other variables 
it does not add to the overall variance. The reason for this may be rooted 
in other variables and their effect on MCS, such as appropriate coping 
strategies [26], lower levels of apathy and depression and higher levels 
of cognition and self-efficacy in people who agreed to participate in the 
study [27].
Strengths and Limitations
The main strength of this study is the approach regarding social 
participation on the basis of peer comparisons with the HRQoL. This, 
although without a control group, gives us a better understanding of 
social participation in one’s specific conditions and not only a comparison 
with the general average population. Some limitations should be noted, 
however. Although the women-to-men ratio in MS is generally 2:1, in our 
sample this ratio was higher (72.4% women); thus, the results may be better 
applied to HRQoL among women than among men. Also, people with a 
lower disease severity (mean EDSS 3.24) were more likely to participate in 
the study, while people with a more serious disability were more likely to 
refuse to participate. Thus, the findings can be generalized to people with 
lower disease severity and not to the whole populations of people with 
MS. Another limitation of the study is a similar focus of the p-scale, which 
refers to the phenomenon of performing one’s role in society or taking 
part in activities in a group situation, and the role limitations subscale of 
the SF-36, which is focused on problems with work or other daily activities 
as a result of physical limitations. On the other hand, it measures social 
participation with far fewer items, does not involve the concept of peer 
comparison and is only a small part of the MCS dimension, with no links 
to PCS, which is the reason why we decided to use this measurement. 
Finally, HRQoL measured by the SF-36 can be considered as not entirely 
accurate, as this measurement is closely linked with functional status 
rather than with health, and functional limitation may be the reason for 
the negative bias [28]. 
Conclusion
This study is beneficial in that it shows that social participation is very 
important for PCS in people with MS. According to our results, isolation 
and avoiding social activities are associated with lower HRQoL in people 
with MS. Hiding from social activities may seem comfortable and easy, as it 
eliminates the stress from obstacles to social participation caused by health 
problems, but this study indicates that there is an association between 
social participation and PCS. This could be the basis for an intervention 
program for people with MS, where they could be educated about ways in 
which social activities can benefit them and can be encouraged to engage 
in social participation even if physical obstacles make it more difficult. This 
can also be beneficial for caretakers of these people, who can encourage 
them to engage in social activities and to visit family, friends or clubs for 
people with MS. Future research is needed, however, to determine the 
causality of the relationship between PCS and social participation. These 
recommendations can be included in intervention programs focused on 
social participation and tested by experimental design.
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Chapter 5
Can coping make you less tired? 
The mediating effect of coping on 
the association between fatigue and 
quality of life in patients with 
multiple sclerosis
Pavol Mikula, Iveta Nagyova, Martina Krokavcova, Marianna Vitkova, 
Jaroslav Rosenberger, Jarmila Szilasiova, Zuzana Gdovinova, Johan W 




Fatigue, as one of the most frequent symptoms in patients with multiple 
sclerosis (MS) has various adverse effects on physical and mental health-
related quality of life (PCS, MCS) of MS patients. Aim of this study is to 
explore whether coping mediates the relationship between fatigue and 
PCS and MCS.
Methods
We collected 154 consecutive MS patients (response rate: 72.7%; 76.0% 
women; mean age 40.0±9.9). Patients completed the Short-Form Health 
Survey (SF-36) for measuring PCS and MCS, the Multidimensional 
Fatigue Inventory (MFI-20) for measuring five dimensions of fatigue and 
the Coping Self-Efficacy Scale (CSE) for measuring three types of coping. 
The mediating effect of coping was analysed using linear regressions and 
with the Sobel Z test.
Results
In PCS, problem-focused coping mediated significantly the effect of 
general and physical fatigue, emotion-focused coping mediated effect of 
general fatigue, and in case of coping focused on stopping unpleasant 
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emotions and thoughts, the mediating effect was present in general 
fatigue and reduced motivation. In MCS, coping mediations were present 
in all five types of fatigue no matter which type of coping was mediating.
Conclusions
Coping was a significant mediator in all dimensions of the association 
between fatigue and MCS, while regarding fatigue and PCS coping 
seems to be much less important. These results can be implemented into 
educational programs for patients, their caregivers or physicians and can 
also be helpful in the treatment process.
Keywords: Multiple sclerosis, fatigue, coping, physical component of 
quality of life, mental component of quality of life 
Introduction
Fatigue is a very frequent symptom in multiple sclerosis (MS) patients. It 
affects the majority of the MS population and many patients consider it 
as their most serious symptom [1]. Unlike short-term fatigue which seems 
to be a universal symptom experienced by a substantial percentage of 
the population [2], chronic fatigue plays an integral role, is a significant 
aspect of the experience of living with a long-term health condition and 
all areas of daily living are affected by it [3]. Fatigue is rooted in brain 
tissue changes such as demyelination and axonal damage and it correlates 
with psychological symptoms as well [4]. 
Although fatigue is not uncommon even in a healthy or in a benign 
MS population, MS patients report it more often, with an adverse effect on 
their quality of life [5,6]. More than half of all MS patients consider fatigue 
as their worst symptom [7]. It is closely related to the physical component 
of quality of life (PCS) [8,9], and can lead to longitudinal changes in the 
activity pattern of MS patients [10]. Various activities, such as exercise, 
can be difficult to perform because of the constant present fatigue, which 
only deepens the adverse effects of MS on PCS, although an exercise itself 
can have a positive effect on fatigue and on PCS [11,12]. Some studies 
suggest that especially modifying mental fatigue as an intervention 
seems to be positively associated with exercise and physical activity [13]. 
Fatigue seems to affect the mental component of quality of life (MCS) as 
well [8,14]. Fatigue goes hand in hand with depression and is strongly 
associated with inactivity and worsening mental quality of life [15]. 
Stress can affect patients with MS in different ways as the general 
population. It can accelerate MS relapses and thus increase patients’ 
disability by inflammatory processes which worsen neurodegeneration 
[16]. Stress is also one of the factors closely tied to fatigue in MS patients 
[17]. Coping strategies used in dealing with stress, from the diagnosis 
itself or other stressors, are crucial in maintaining good quality of life 
[18]. Various studies focused on coping and its influence on quality of 
life. Many of them resulted in praising active, problem oriented coping 
[19,20], especially compared to avoidance coping [21], although in some 
cases emotion-focused coping was perceived as the most adaptive [22] 
and in some studies even avoidance coping is regarded as adaptive, 
especially when it is used in situation when the patient does not have 
enough control over the situation [23,24].  
Although there are studies dealing with fatigue in MS and studies 
focused on different coping strategies used by these patients, not 
much attention was paid to the mediating role of coping regarding the 
relationship between fatigue and quality of life. Thus, the aim of this 
study is to explore how the three different forms of coping mediate the 
relationship between the five dimensions of fatigue and PCS and MCS 
separately in patients with MS.
Methods
Participants
McDonald criteria were used as inclusion criteria, and patients who met 
them, were asked to participate in the study [25]. Out of 213 consecutive 
MS patients from the Department of Neurology of the Louis Pasteur 
University Hospital in Košice, 58 (24 men and 34 women, response rate 
72.7%) refused to participate in the study. On rest of the sample, exclusion 
criteria were applied. Those consisted of psychiatric diagnosis, Mini-
Mental State Examination (MMSE) <24, pregnancy and the inability to 
speak Slovak. Based on these criteria 1 patient was excluded from the 
study. The final sample (N=154) consisted of 76.0% women, with a mean 
age of 40.0±9.9 years (range 18-61 years). There were no statistically 
significant differences between responders and non-responders in terms 
of gender or age.
Procedure
The data collection for this cross-sectional study took place between 
September 2010 and March 2013. Data collection consisted of filling in self-
reported questionnaire, a semi-structured interview and a neurological 
examination. The invitation letter, the informed consent form, the non-
response sheet and the questionnaires were sent to participants’ homes 
by postal mail. Patients were reminded about the questionnaires by 
a phone call two weeks later. During this phone call their interview and 
neurological examination was scheduled as well. These then took place 
at the Neurology Outpatient Clinic. The neurological examination was 
carried by one single neurologist and a trained interviewer conducted the 
semi-structured interview.
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The Ethics Committee of the Faculty of Medicine of the PJ Safarik 
University approved the study before it started. Each patient provided 
a signed informed consent form prior to the study. 
Measures
All questionnaires used in this study were translated from the original 
language. Next, backwards translation was made to ensure that the 
meaning was not lost in translation. Final changes in translated version 
were made accordingly.
Health-related quality of life (HrQoL)
For assessing HRQoL the 36-item Short-Form (SF-36) health survey was 
used [26]. Its 8 dimensions cover various aspects of HRQoL which than can 
be summarized into two components. Scales included in the questionnaire 
are: 1. Physical functioning (ten items), 2. Role limitation due to physical 
health (four items), 3. Bodily pain (two items), 4. General mental health 
(five items) 5. Social functioning (two items), 6. Psychological distress 
and well-being (five items), 7. Role limitations due to emotional problems 
(three items), 8. Vitality, energy or fatigue (four items). Four scales form 
the Physical Component Summary (PCS) and other four the Mental 
Component Summary (MCS). In addition, one question covers changes 
in health status over the past year (one item). All item scores are coded 
and transformed for the PCS and the MCS into a scale of 0 (poor health) 
to 100 (optimal health). A higher score indicates better health in both 
dimensions. In our sample Cronbach´s alpha was 0.92 for the PCS and 
0.93 for the MCS. 
Fatigue
Fatigue was assessed by Multidimensional Fatigue Inventory (MFI) [27], 
which is commonly used in patients with chronic conditions [28,29]. 
It consists of 5 dimensions: General Fatigue (4 items), Physical Fatigue 
(4 items), Mental Fatigue (4 items), Reduced Motivation (4 items), and 
Reduced Activity (4 items).
Patients were asked to share how much they agree with statements 
like: “I feel fit”, “I feel very active” or “Physically I feel only able to do a 
little” on a 5-point scale anchored in quotes: “Yes, that is true” and “No, 
that is not true”, where higher score indicated more prevalent fatigue 
in all 5 scales. 10 of the items are worded in a negative way to prevent 
tendencies towards the response set, and scores for these items were 
calculated accordingly. In our sample, Cronbach´s alpha was 0.79 for 
General Fatigue, 0.84 for Physical Fatigue, 0.81 for Reduced activity, 0.64 
for Reduced Motivation, and 0.78 for Mental fatigue.
Coping self-efficacy
Coping self-efficacy was measured using the 26-item Coping Self-Efficacy 
Scale (CSE) developed specifically for chronically ill populations [30]. CSE 
is a prerequisite for using actual coping strategies as patients need to be 
sure, they can perform coping actions before they act upon them. That 
is, why in this article we treat terms coping and coping self-efficacy as 
equivalent, because both concepts are closely tied to each other. Patients 
were asked to respond to the following question: ‘When things are not 
going well for you, or when you’re having problems, how confident or 
certain are you that you can do the following’. Respondents then had 
to give the extent to which they believe they could perform each coping 
behaviour on an 11-point scale. The instrument consists of three subscales 
representing self-efficacy for the use of problem-focused coping strategies 
(ranging from 0-120), the ability to stop unpleasant emotions and thoughts 
(ranging from 0-90), and finally the ability to get support from friends 
and family (ranging from 0-50). A higher score indicates a higher ability 
to cope with the situation described in the question [30]. In our sample 
Cronbach´s alpha was 0.94 for problem-focused coping, 0.86 for coping 
focused on getting support, and 0.93 for stopping unpleasant emotions 
and thoughts.
Clinical variables
We used medical records to obtain information on EDSS (score ranges 
from 0.0 to 10.0, with a higher score indicating more severe disability) [31] 
and the clinical course of MS. Patients were categorised in the clinically 
isolated syndrome (CIS) group with high risk of conversion to clinically 
definite MS [32], the relapse-remitting (RRMS) course of MS or the 
secondary-progressive (SPMS) course of MS [33].
Sociodemographic variables
Data on age (treated as continuous variable), gender, education 
(elementary, high school and university) were retrieved during the 
interview. 
Statistical analyses
Firstly, descriptive analyses of the study variables were carried out. Next, 
correlations and multiple regressions between variables were carried out 
in order to calculate data for mediations. Finally, the mediating effect 
using the Sobel z-test of the three different coping strategies on all five 
dimensions of fatigue and both components of quality of life in MS 
patients were examined. Statistical analyses were performed in IBM SPSS 
20 and MedGraph [34].
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results
A basic description of the study population is given in Table 5.1 (n=154). 
The MS respondents averaged 40.05 years and consisted of 76.0% women. 
The mean EDSS score was 3.12, the mean disease duration 7.1 years. The 
majority of the patients (78.3%) belonged to relapse-remitting clinical 
course (Table 5.1).
 
Table 5.1 Description of the study population (N=154)
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Table	  5.1:	  Description	  of	  the	  study	  population	  (N=154)	  
Variables	   N	  (%)	   Mean	   SD	   Range	  
Age	  (years)	   154	   40.05	   9.97	   18-­‐61	  
Gender	   	   	   	   	  
	  	  	  male	   37(24.0%)	   	   	   	  
	  	  	  female	   117(76.0%)	   	   	   	  
Education	   	   	   	   	  
	  	  	  elementary	   6(3.9%)	   	   	   	  
	  	  	  high	  school	   110(71.9%)	   	   	   	  
	  	  	  university	   37(24.2%)	   	   	   	  
Disease	  duration	  
(years)	  
	   7.11	   5.74	   1-­‐28	  
MS	  course	   	   	   	   	  
	  	  	  CIS	   11(9.2%)	   	  	  	  	  	   	   	  
	  	  	  RRMS	   94(78.3%)	   	   	   	  
	  	  	  SPMS	   15(12.5%)	   	   	   	  
EDSS	   	   3.12	   1.33	   1.0-­‐8.0	  
Fatigue	   	   	   	   	  
	  	  	  general	  fatigue	   	   13.99	   4.44	   4-­‐20	  
	  	  	  physical	  fatigue	   	   13.42	   4.86	   4-­‐20	  
	  	  	  reduced	  activity	   	   10.96	   4.74	   4-­‐20	  
	  	  	  reduced	  motivation	   	   8.56	   3.65	   4-­‐20	  
	  	  	  mental	  fatigue	   	   10.38	   4.50	   4-­‐20	  
Coping	   	   	   	   	  
	  	  	  problem	   	   80.18	   22.36	   22-­‐120	  
	  	  	  emotion	   	   34.00	   10.01	   3-­‐50	  
	  	  	  stopping	   	   59.16	   19.29	   4-­‐90	  
Quality	  of	  life	  	   	   	   	   	  
	  	  	  PCS	   	   38.52	   11.26	   16-­‐60	  
	  	  	  MCS	   	   42.94	   12.22	   17.39-­‐69.85	  
CIS	  –	  Clinically	   Isolated	  Syndrome;	  RRMS	  –	  Relaps-­‐Remitting	  Multiple	  Sclerosis;	  SPMS	  –	  Simple	  Progressive	  Multiple	  Sclerosis;	  
EDSS	  –	  Expanded	  Disability	  Status	  Scale;	  PCS	  –	  Physical	  Component	  Summary;	  MCS	  –	  Mental	  Component	  Summary;	  
Missing	  values:	  EDSS:	  (17.5%),	  Education:	  (0.6%),	  Disease	  duration:	  (9.7%)	  ,	  MS	  course:	  (22.0%),	  	  
	  
	  
CIS – Clinically Isolated Syndrome; rrMS – relaps-remitting Multiple Sclerosis; SPMS – Simple 
Progressive Multiple Sclerosis; eDSS – expanded Disability Status Scale; PCS – Physical 
Component Summary; MCS – Mental Component Summary;
Missing values: eDSS: (17.5%), education: (0.6%), Disease duration: (9.7%) , MS course: (22.0%) 
Multiple mediations were used to determine the mediating effect of 
the three different coping strategies on the relationship between the 
five different types of fatigue and both PCS and MCS. The outcomes 
of the mediations showed that in PCS all coping strategies mediate the 
association with general fatigue. Besides that, problem-focused coping 
mediates the association with physical fatigue and coping focused on 
stopping unpleasant emotions and thoughts mediates the association 
with reduced motivation. In MCS, coping was generally involved 
in the associations between all dimensions of fatigue and MCS as it is 
statistically significantly and substantially mediated all different variable 
combinations (Table 5.2).
 
Table 5.2 The mediating effect of coping on the association between fatigue and PCS and MCS
64	  
	  
Multiple	   mediations	   were	   used	   to	   determine	   the	   mediating	   effect	   of	   the	   three	   different	   coping	  
strategies	  on	   the	   relationship	  between	   the	   five	  different	   types	  of	   fatigue	  and	  both	  PCS	  and	  MCS.	  The	  
outcomes	   of	   the	   mediations	   showed	   that	   in	   PCS	   all	   coping	   strategies	   mediate	   the	   association	   with	  
general	   fatigue.	   Besides	   that,	   problem-­‐focused	   coping	  mediates	   the	   association	   with	   physical	   fatigue	  
and	   coping	   focused	   on	   stopping	   unpleasant	   emotions	   and	   thoughts	   mediates	   the	   association	   with	  
reduced	  motivation.	   In	  MCS,	  coping	  was	  generally	   involved	  in	  the	  associations	  between	  all	  dimensions	  
of	   fatigue	   and	   MCS	   as	   it	   is	   statistically	   significantly	   and	   substantially	   mediated	   all	   different	   variable	  
combinations	  (Table	  5.2).	  
	  	  
Table	  5.2:	  The	  mediating	  e fect	  of	  c i 	   	   	   sociation	  between	  fatigue	  and	  PCS	  and	  MCS	  
	   	   PCS	   MCS	  












General	  Fatigue	  	  (GF)	   2.34	   0.01*	   12.0%	   -­‐3.65	   0.00*	   26.9%	  
Physical	  Fatigue	  (PF)	   1.92	   0.05	   	   -­‐3.27	   0.00*	   30.6%	  
Reduced	  Activity	  (RA)	   1.47	   0.13	   	   -­‐3.12	   0.00*	   23.3%	  
Reduced	  Motivation	  (RM)	   1.32	   0.18	   	   -­‐3.38	   0.00*	   24.8%	  
Mental	  Fatigue	  (MF)	   0.74	   0.45	   	   -­‐3.24	   0.00*	   21.0%	  
	   	   	   	   	   	   	   	  
Emotions	  
General	  Fatigue	  	  (GF)	   2.00	   0.04*	   9.3%	   -­‐3.25	   0.00*	   22.8%	  
Physical	  Fatigue	  (PF)	   1.81	   0.06	   	   -­‐3.01	   0.00*	   26.4%	  
Reduced	  Activity	  (RA)	   1.44	   0.14	   	   -­‐2.97	   0.00*	   21.0%	  
Reduced	  Motivation	  (RM)	   1.49	   0.13	   	   -­‐2.80	   0.00*	   21.2%	  
Mental	  Fatigue	  (MF)	   0.65	   0.50	   	   -­‐2.88	   0.00*	   17.8%	  
	   	   	   	   	   	   	   	  
Stopping	  
General	  Fatigue	  	  (GF)	   2.86	   0.00*	   15.0%	   -­‐3.78	   0.00*	   29.5%	  
Physical	  Fatigue	  (PF)	   1.97	   0.04*	   5.1%	   -­‐2.79	   0.00*	   26.9%	  
Reduced	  Activity	  (RA)	   1.77	   0.07	   	   -­‐2.83	   0.00*	   22.5%	  
Reduced	  Motivation	  (RM)	   2.46	   0.01*	   32.6%	   -­‐3.71	   0.00*	   30.4%	  






The aim of this study was to find out whether and how three different 
coping strategies mediate the associations between the five dimensions of 
fatigue and both PCS and MCS separately. Our results provided evidence 
that all three types of coping mediate this relationship and are a mediator 
of the association between all five dimensions of fatigue and MCS, and 
mainly between general fatigue and PCS.
Regarding PCS, statistical analyses showed mild mediations of all 
three types of coping in general fatigue, suggesting that effective coping 
strategies can be beneficial for patients, which is in line with findings in 
other chronic conditions [35,36]. Besides general fatigue, only physical 
fatigue and reduced motivation in stopping unpleasant emotions and 
thoughts were mediated by coping in PCS from which reduced motivation 
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seemed to be buffered most, indicating that stopping thoughts about MS 
can help patients to increase their motivation, which then has a positive 
effect on PCS.
Whereas in PCS, coping seems to be only partially significant or 
in most cases not significant at all, in MCS its buffering effect proved to 
be significant in all cases. Appropriate coping strategies seem to act as 
a buffering effect in many situations dealing with chronic health conditions 
[37,38], and in case of all dimensions of fatigue in MS, it indirectly affects 
this relationship as well. Coping seems to mitigate the adverse effect of 
fatigue on MCS in various cases of chronic diseases [39,40], even in cases 
when it may have negative effect on physical functioning, coping might 
soften fatigue effects [41]. 
The reason why coping is generally more prominent in the association 
between fatigue and MCS, rather than in the association between fatigue 
and PCS, may be explained by the fact that patients have very little control 
over their disease. MS is in most patients a chronic progressive disease 
and no optimal cure has thus far been found [42], so when patients lose 
the ability to control the disease and have to learn how to live with it, 
coping can help them to reduce the stress that MS brings and thus improve 
their MCS, while PCS is not affected in such extent. These results suggest 
that problem-focused coping, emotion-focused coping and even coping 
focused on stopping unpleasant emotions and thoughts are important 
factors in effective dealing with one of the most prevalent and disabling 
symptoms patients with MS have to deal with.
Strengths and limitations
Among the strengths of this study belong the high response rate (72.7%), 
and the consecutive way of collecting data. Some limitations should be 
noted, however. Although the women–to-men ratio in MS is 2:1, in studied 
sample the ratio was higher (76.0% women), so the results may better 
explain fatigue, coping and the quality of life of women than men. Also, 
patients with a lower disease severity (mean EDSS 3,2) were more likely to 
participate in the study, while patients with a more serious disability were 
more likely to refuse to participate.
Implications
Based on the results of this study, the associations between fatigue with 
both PCS and MCS seem to be mediated by coping strategies, although 
only in MCS these associations seem universal for all dimensions of 
fatigue, while in PCS it was mainly general fatigue. This study may be 
beneficial in bringing a new perspective into the complicated relationship 
between fatigue, coping and HRQoL. Coping in some cases may reduce 
the adverse effect of fatigue on PCS, and may act as a protective factor in 
MCS. This information can be implemented into educational programs 
for patients with MS, can be shared with health professionals, caregivers 
and patients themselves in order to help them learn how to live with 
symptoms of MS. Understanding of this relationship can be also beneficial 
in therapy as well. In particular such forms of treatment that work with 
techniques that can diminish the effect of fatigue in patients with chronic 
conditions [43,44], either in long individual therapies or education about 
the role of coping which can be included in shorter pragmatic programs 
[45]. Future research into coping as a mediator of the relationship between 
fatigue and both PCS and MCS in the therapy process is needed though 
as well as unravelling the pathway between these three variables during 
the course of the disease.
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Chapter 6
Do coping strategies mediate the 
association between type D personality 
and quality of life among patients with 
multiple sclerosis?
Pavol Mikula, Iveta Nagyova, Martina Krokavcova, Marianna Vitkova, 
Jaroslav Rosenberger, Jarmila Szilasiova, Zuzana Gdovinova, Johan W 




The aim of this study is to explore whether different coping strategies are 
able to mediate the association between Type D personality and quality of 
life in patients with multiple sclerosis.
Methods
We collected information from 156 consecutive patients with multiple 
sclerosis (response rate: 72.9%; 75.0% women; median age 40±3). Patients 
completed the Type-D Scale-14, the Coping Self-Efficacy Scale and the 
Short-Form Health Survey. The mediating effect of coping was analysed 
using correlations, linear regressions and the Sobel z-test.
Results
In PCS no mediation was found between the studied variables. In MCS all 
three studied coping strategies mediated the association between Type D 
personality and quality of life (Sobel z=-3.7 for problem focused coping, 
z=-3.37 for emotion focused coping and z=-4.11 for coping focused on 
stopping unpleasant emotions and thoughts).
Conclusions
Coping is able to mediate the association between Type D personality and 
MCS but not with PCS. This result can be used in educational programmes 
for patients, psychotherapies and counselling. Caregivers and physicians 
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can encourage patients to use various coping strategies in order to mitigate 
the adverse effects of Type D personality on a patient’s quality of life.
Keywords: Type D, coping, physical component of quality of life, mental 
component of quality of life
Introduction
Multiple Sclerosis (MS) is a chronic neurological disease causing 
dysfunctions which can be manifested in a wide range of symptoms, 
including fatigue, balance impairments, sleep problems and pain [1]. 
Besides these physical symptoms, psychological symptoms are common 
as well, including depression, anxiety, low self-esteem or somatization 
[2]. All of these symptoms affect health-related quality of life (HRQoL) in 
both the physical (PCS) and mental (MCS) domains [3].
Given its unpredictable course [4], the experience of MS can be highly 
subjective, taking into account not only objective symptoms, but also the 
personality of patients. The reactions of patients to the diagnosis can vary 
from frustration to the feeling that their identity has been assaulted [5]. 
In the past various diseases were associated with different personality 
types, for example type A personality was associated with cardiovascular 
diseases [6,7]. Type D personality was later described as a type in which 
negative affectivity (NA) and social inhibition (SI) are prominent [8,9]. 
NA is manifested in high levels of distress and dissatisfaction regardless 
of the time or situation, even when a person is not threatened by a 
stressful situation. It can be said that in general, people with the NA trait 
tend to focus on the negative side of things [10]. SI is a more passive trait 
describing stable tendencies to inhibit behaviour and emotional response 
during social interaction [11]. Type D personality has been found to be 
associated with poorer health status and independently tied to symptoms 
of depression and anxiety in various health-threatening conditions [12-
14] and it has been shown to have an effect on physical (PCS) and mental 
quality of life (MCS) in patients with MS and Parkinson’s disease [15].
Symptoms of MS and the diagnosis itself threaten to change a 
person’s everyday habits and bring disarray into the life of patients who 
find themselves facing all kinds of issues resulting from their disease. To 
manage such a situation, one requires functional coping strategies [16]. 
Patients, while dealing with their condition, engage in various coping 
strategies [17,18] which do not have the same effect on the patient’s 
well-being [19]. Multiple studies have focused on the effect of different 
coping strategies on quality of life. Some studies indicate that problem-
focused coping is the most adaptive [16,20]; in others, a lesser reliance on 
avoidance coping was found to be more adaptable [21], and some came 
to the conclusion that coping focused on stopping unpleasant emotions 
and thoughts has its place in dealing effectively with chronic conditions 
as well [22,23]. Adequate coping strategies also seem to differ between 
patients with different diagnoses, such as when laryngectomized patients, 
for example, use an active coping more often than MS patients, while MS 
patients utilize more coping by suppression and so on [24].
Both Type D personality and coping seem to be associated with 
HRQoL, and although personality traits are relatively stable over time 
[25], coping seems to have its own independent influence on quality of 
life in patients with a chronic disease. The aim of this study was to thus 
analyse the associations between Type D personality and HRQoL in 
MS patients and to explore whether this association is mediated by the 
different coping strategies used by patients with MS.
Methods
Participants
MS patients from the Department of Neurology of Louis Pasteur 
University Hospital in Košice who met the McDonald criteria [26] were 
asked to participate in the study (n=214). Out of these, 58 patients (60.3% 
women) refused to participate (response rate: 72.9%), and the exclusion 
criteria were applied to the rest. These were as follows: the presence of 
a psychiatric diagnosis, the score on the Mini-Mental State Examination 
(MMSE) <24, pregnancy and the inability to speak Slovak. The final sample 
(N=156) had a median age of 403± years and consisted of 75.0% women. 
There were no statistically significant differences between respondents 
and non-respondents in terms of gender and age. 
Procedure
Data collection for this cross-sectional study took place between 
September 2010 and June 2013. Filling in self-report questionnaires, a semi-
structured interview and a neurological examination were the parts of 
the data collection. The invitation letter, the informed consent form, the 
non-response sheet and the questionnaires were sent to participants’ 
homes by postal mail. Two weeks later, patients were reminded about the 
questionnaires by a phone call, and their neurological examination and 
interview were scheduled at the same time. These were performed at the 
Neurology Outpatient Clinic. The neurological examination was carried 
by a single neurologist, and a trained interviewer conducted the semi-
structured interview.
The Ethics Committee of the Faculty of Medicine of Safarik 
University in Kosice approved the study before it started. Each patient 
provided a signed informed consent form prior to the study.
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Measures
Type D
The presence of Type D personality among patients with MS was assessed 
using the Type D Scale 14 (DS14) [11]. It consists of 14 items used to build 
2 scales – Negative Affectivity (NA) and Social Inhibition (SI), each 
consisting of 7 items. Patients assessed their personality on a 5-point 
Likert scale with anchor points ranging from 0=false to 4=true. The score 
on both scales can range from 0 to 28, with a higher score indicating higher 
inclination to NA or SI. A cut-off score of 10 was set in both scales as the 
point when subjects would be considered as Type D [11]. In our sample 
Cronbach’s alpha was 0.89 for NA, 0.84 for SI and 0.89 for Type D. We 
treated Type D as a continuous variable.
Coping self-efficacy
Coping self-efficacy was measured using the 26-item Coping Self-Efficacy 
Scale (CSE) developed specifically for chronically ill populations [27]. 
The CSE is a prerequisite for using actual coping strategies, as patients 
need to be sure that they can perform coping actions before they act upon 
them. Therefore, in this article we treat the terms coping and coping self-
efficacy as equivalent, because both concepts are closely tied to each other. 
In this questionnaire, patients were asked to respond to the following 
question: ‘When things are not going well for you, or when you’re having 
problems, how confident or certain are you that you can do the following’. 
Respondents then answered on an 11-point scale. The instrument included 
three subscales representing self-efficacy for the use of ‘problem-focused 
coping’ strategies (ranging from 0-120), ‘emotion-focused coping’ meaning 
ability to get support from friends and family (ranging from 0-50) and the 
‘ability to stop unpleasant emotions and thoughts’ (ranging from 0-90). A 
higher score indicates a higher ability to cope with the situation described 
in the question [27]. In our sample Cronbach´s alpha was 0.94 for problem-
focused coping, 0.86 for coping focused on getting support and 0.93 for 
stopping unpleasant emotions and thoughts.
Health-related quality of life (HRQoL)
HRQoL was assessed using the 36-item Short-Form (SF-36) health survey 
[28]. Various aspects of HRQoL are covered in 8 scales, which then can 
be summarised into two main components. The subscales included 
in the questionnaire are: 1. Physical functioning (ten items), 2. Role 
limitation due to physical health (four items), 3. Bodily pain (two items), 
4. General mental health (five items), 5. Social functioning (two items), 6. 
Psychological distress and well-being (five items), 7. Role limitations due 
to emotional problems (three items), and 8. Vitality, energy or fatigue (four 
items). Two summary scores are calculated, namely a Physical Component 
Summary (PCS) and a Mental Component Summary (MCS). In addition, 
one question is designed to measure changes in health status over the 
past year. All item scores are coded and transformed into a scale of 0 
(poor health) to 100 (optimal health). The component summary scores are 
normalised to a general population mean of 50 and a standard deviation 
of 10. A higher score indicates better HRQoL in both dimensions. In our 
sample Cronbach´s alpha was 0.92 for the PCS and 0.93 for the MCS. 
Sociodemographic and clinical variables
For the description of our study population we used the Expanded 
Disability Status Scale (EDSS) score as a measure of functional disability 
in MS patients (scoring from 0.0 to 10.0), with an increasing score 
indicating more severe disability [29]. Information on the clinical course 
of MS was retrieved from medical records. The age (treated as continuous 
variable) of patients along with the information on gender and education 
(elementary, secondary and university) were asked during the interview.
Statistical analyses
Firstly, descriptive analyses of the study variables were carried out. Next, 
correlations and a series of linear regression analyses were carried out 
in order to calculate the figures for mediations. Finally, the Sobel z-test 
was used to examine the mediating effects of the three different coping 
strategies on the association of Type D and both components of quality 
of life in MS patients. Statistical analyses were performed in IBM SPSS 20 
and MedGraph [30].
results
A basic description of the study population is given in Table 6.1 (N=156). 
The median age of MS respondents was 40 years, and the sample consisted 
of 75.0% women. The median EDSS score was 3, and the median disease 
duration was 6 years. The majority of patients (68%) belonged to relapse-
remitting clinical course (Table 6.1).
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Table 6.1 Description of the study population (N=156)
77	  
	  
Table	  6.1:	  Description	  of	  the	  study	  populati 	  ( )	  
Variables	   N	  (%)	   Median	   95%	  CI	   Range	  
Age	  (years)	   156	   40.0	   37-­‐43	   18-­‐61	  
Gender	   	   	   	   	  
	  	  	  male	   39(25.0%)	   	   	   	  
	  	  	  female	   117(75.0%)	   	   	   	  
Education	   	   	   	   	  
	  	  	  elementary	   6(3.8%)	   	   	   	  
	  	  	  secondary	   113(72.4%)	   	   	   	  
	  	  	  university	   37(23.7%)	   	   	   	  
Disease	  duration	  
(years)	  
	   6	   5-­‐8	   1-­‐28	  
MS	  course	   	   	   	   	  
	  	  	  CIS	   19(12.4%)	   	  	  	  	  	   	   	  
	  	  	  RRMS	   104(68.0%)	   	   	   	  
	  	  	  SPMS	   30(19.6%)	   	   	   	  
EDSS	   	   3	   2.5-­‐3.5	   1.0-­‐8.0	  
Type	  D	   	   	   	   	  
	  	  	  negative	  affectivity	   	   12	   10-­‐14	   0-­‐28	  
	  	  	  social	  inhibition	   	   10	   9-­‐12	   1-­‐24	  
Coping	   	   	   	   	  
	  	  	  problem	   	   83.5	   77-­‐87	   22-­‐120	  
	  	  	  emotion	   	   35.0	   33-­‐38	   3-­‐50	  
	  	  	  stopping	   	   63.0	   58-­‐67	   4-­‐90	  
Quality	  of	  life	  	   	   	   	   	  
	  	  	  PCS	   	   38.1	   35.1-­‐40.4	   16.0-­‐60.0	  
	  	  	  MCS	   	   43.1	   38.9-­‐47.8	   17.3-­‐69.8	  
CIS	  –	  Clinically	  Isolated	  Syndrome;	  RRMS	  –	  Relapse-­‐Remitting	  Multiple	  Sclerosis;	  SPMS	  –	  Simple	  Progressive	  Multiple	  Sclerosis;	  
EDSS	  –	  Expanded	  Disability	  Status	  Scale;	  PCS	  –	  Physical	  Component	  Summary;	  MCS	  –	  Mental	  Component	  Summary;	  CI	  –	  
Confidence	  intervals	  
Missing	  values:	  EDSS:	  (9.6%),	  Disease	  duration:	  (3.2%),	  MS	  course:	  (1.9%) 
	  
Before	   we	   proceeded	   with	   the	   mediations,	   we	   prepared	   the	   data,	   starting	   with	   correlations,	   which	  
showed	   us	   that	   PCS	   was	   not	   correlated	   with	   other	   studied	   variables,	   while	   MCS	   was	   correlated	  
significantly.	  Coping	  strategies	   intercorrelated	  significantly.	  Finally,	  Type	  D	  correlated	  significantly	  with	  
all	  of	  the	  studied	  variables	  except	  for	  PCS	  (Table	  6.2).	  
	  	  
	   	  
CIS – Clinically I olated Syndrome; rrMS – relapse-remitting Multiple Sclerosis; SPMS – 
Simple Progressive Multiple Sclerosis; eDSS – expanded Disability Status Scale; PCS – Physical 
Component Summary; MCS – Mental Component Summary; CI – Confidence intervals
Missing values: eDSS: (9.6%), Disease duration: (3.2%), MS course: (1.9%)
Before we proceeded with the mediations, we prepared the data, 
starting with cor elatio s, which showed us that PCS was not correlated 
with other studied variables, while MCS was correlated significantly. 
Coping strategies intercorrelated significantly. Finally, Type D correlated 
significantly with all of the studied variables except for PCS (Table 6.2).
 
Table 6.2 Correlations between the variables under study
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Table	  6.2:	  Correlations	  between	  the	  v ri l s	   er	  study	  
	   HRQoL	   Coping	   Type	  D	  





Stopping	  	   	  
MCS	   0.079	   	   	   	   	   	  
Problem-­‐
focused	  	  
0.091	   0.476*	   	   	   	   	  
Emotion-­‐
focused	  	  
0.099	   0.448*	   0.852*	   	   	   	  
Stopping	   0.039	   0.512*	   0.875*	   0.840*	   	   	  
Type	  D	   -­‐0.090	   -­‐0.428*	   -­‐0.428*	   -­‐0.475*	   -­‐0.484*	   	  
PCS	  –	  Physical	  Component	  Summary;	  MCS	  –	  Mental	  Component	  Summary;	  Stopping	  –	  Coping	  focused	  on	  stopping	  unpleasant	  
emotions	  and	  thoughts;	  *p<.05	  
	  
Next,	  we	  performed	  a	  series	  of	  linear	  regressions	  between	  the	  studied	  variables,	  thus	  preparing	  data	  for	  
the	   mediations.	   The	   outcomes	   of	   the	   analyses	   showed	   that	   while	   in	   the	   PCS	   there	   is	   no	   mediation	  
between	  the	  studied	  variables,	   in	  the	  MCS	  partial	  mediations	  in	  all	  three	  types	  of	  coping	  were	  present	  
(Table	  6.3).	  
	  	  
Table	  6.3:	  The	  mediating	  effect	  of	  coping	  on	  the	  association	  between	  Type	  D	  and	  PCS	  and	  MCS	  
	   Type	  D	   	   	  
	   PCS	   MCS	  






Problem-­‐focused	  coping	   -­‐0.72	   	   -­‐3.70*	   35.9%	  
Emotion-­‐focused	  coping	   -­‐0.79	   	   -­‐3.37*	   34.3%	  
Coping	  focused	  on	  stopping	  
unpleasant	  emotions	  and	  thoughts	  
-­‐0.05	   	   -­‐4.11*	   45.0%	  
The	  indirect	  effect	  is	  shown	  only	  when	  significant	  
*p<.05	  
	  
In	  the	  MCS	  the	  indirect	  mediating	  effect	  of	  all	  three	  coping	  strategies	  was	  significant.	  The	  indirect	  effect	  
was	  35.9%	  for	  problem-­‐focused	  coping,	  34.3%	  for	  emotion-­‐focused	  coping	  and	  45.0%	  for	  coping	  focused	  
on	   stopping	   unpleasant	   emotions	   and	   thoughts.	   A	   detailed	   model	   of	   how	   all	   of	   the	   studied	   coping	  
PCS – Physical Component Summary; MCS – Mental Component Summary; Stopping – Coping 
focused on stopping unpleasant emotions and thoughts; *p<.05
Next, we performed a series of linear regressions between the studied 
variables, thus preparing data for the mediations. The outcomes of the 
analyses showed that while in the PCS there is no mediation between 
the studied variables, in the MCS partial mediations in all three types of 
coping were present (Table 6.3).
 
Table 6.3 The mediating effect of coping on the association between Type D and PCS and MCS
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In	  the	  MCS	  the	  indirect	  mediating	  effect	  of	  all	  three	  coping	  strategies	  was	  significant.	  The	  indirect	  effect	  
was	  35.9%	  for	  problem-­‐focused	  coping,	  34.3%	  for	  emotion-­‐focused	  coping	  and	  45.0%	  for	  coping	  focused	  
on	   stopping	   unpleasant	   emotions	   and	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   A	   detailed	   model	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   how	   all	   of	   the	   studied	   coping	  
The indirect effect s shown only wh n significant
*p<.05
In the MCS th  indirect mediatin  effect of all three c ping s rategi s was 
significant. The indirect effect was 35.9% for problem-focused coping, 
34.3% for emotion-f cu ed coping and 45.0% f r coping foc s  o  
stopping unpleasant emotions and thoughts. A detailed model of how 
all of the studied coping strategies mediate the association between Type 
D and MCS is depicted below, showing the mediating effect of coping 
strategies (Figure 6.1).
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The aim of this study was to examine whether coping mediates the 
association between Type D personality and HRQoL in patients with 
MS. A mediating effect of coping on the association between Type D 
personality and PCS was not present in our results, possibly resulting 
from the objective nature of PCS as a reflection of adverse inflammatory 
processes in the brain tissue or other physical impairments, possibly 
being present [31].
In MCS there seems to be much more space for coping to mediate 
the association between Type D personality and HRQoL. MCS seems 
much more likely to be swayed by coping than its physical counterpart 
[32]. Coping seems to be a factor influencing MCS regardless of the 
specific type of coping. The mental domain seems to have the capacity 
for the self-helping tendencies of patients, and although PCS can be only 
occasionally altered by psychological instruments, MCS responds well to 
various protective efforts [33,34]. While personality traits are considered 
to be rather stable over time, MSC can be possibly altered by coping. 
Strengths and limitations
Among the strengths of this study are the high response rate (72.9%) 
and the consecutive way of collecting data. Some limitations should be 
noted, however. Patients with a lower disease severity were more likely 
to participate in the study, while patients with a higher disability were 
more likely to refuse to participate. Also, although the women-to-men 
ratio in MS is 2:1, in the study sample the ratio was somewhat higher 
(75.0% women), so the results may better explain relationship between 
the studied variables in women than in men. In addition, due to the cross-
sectional design any causal relationships drawn from our results should 
be interpreted with caution.
Conclusion
These results suggest that there is an association between Type D and 
MCS and that this association is partially mediated by different coping 
strategies; no such effect was found with regard to PCS. With coping as 
a mediator between Type D and MCS, one can alter coping strategies in 
order to mediate this association resulting in a better MCS. Although we 
believe Type D personality traits are considered to be fairly stable, coping 
strategies can actively be modified and thus be of great use in diminishing 
the adverse effects of Type D on MCS by educating patients. Various coping 
strategies, especially those focused on stopping unpleasant emotions and 
thoughts, can be used in people with high levels of negative affectivity or 
social inhibition. Coping can also be beneficial for physicians, relatives 
and caretakers of patients with MS. MS clubs and self-help or peer groups 
could include this information into educational programs and encourage 
patients to use problem-focused coping, emotion-focused coping as 
well as coping focused on stopping unpleasant emotions and thoughts, 
especially when Type D personality traits are present. Therapists can 
also work with coping, experiment with different strategies and analyse 
which seem to be most appropriate for different patients. Future research 
is needed though, especially longitudinal studies that would shed more 
light on the causality of the associations between the studied variables.
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Chapter 7
Self-esteem, social participation and 
their association with quality of life in 
patients with multiple sclerosis
Pavol Mikula, Iveta Nagyova, Martina Krokavcova, Marianna Vitkova, 
Jaroslav Rosenberger, Jarmila Szilasiova, Zuzana Gdovinova, Roy E 




Multiple Sclerosis (MS) has the potential to affect negatively patient´s 
social participation and self-esteem. The aim of this study is to explore 
whether self-esteem and social participation are associated with the 
physical and mental domains of quality of life, and whether self-esteem, a 
variable that has the potential to be altered by intervention programs, can 
mediate the association between social participation and health-related 
quality of life (HRQoL).
Methods
We collected information from 118 consecutive MS patients (response 
rate: 76.1%, 72.2% women, median age: 40.5±3 years). Patients completed 
the Participation Scale (P-scale), the Rosenberg Self-Esteem (RSE) scale 
and the Short-Form Health Survey (SF-36) for measuring the physical 
(PCS) and mental (MCS) components of quality of life. Multiple linear 
regressions and structural equation modeling were used for statistical 
analyses.
Results
Age, gender, disease duration, EDSS and participation were significant 
predictors of PCS, explaining 55.4% of the total variance. No mediating 
effect of self-esteem was found between participation and PCS. On the 
other hand, self-esteem fully mediated the association between social 
participation and MCS (Est./S.E.=-4.872; p<0.001), and along with EDSS 
74 CHaPTer 7 75
it explained 48.3% of the variance in MCS.
Conclusions
Self-esteem mediates the association between social participation and 
MCS, but not PCS, and can be used in intervention and educational 
programs for patients and their caregivers.
Keywords: Self-esteem, social participation, multiple sclerosis, physical 
and mental domain of health-related quality of life
Introduction
Symptoms of multiple sclerosis (MS) are of both physical [1] and mental 
[2] nature. The impact of these symptoms makes the life of MS patients 
different from healthy people. Together with social well-being, physical 
and mental aspects are crucial for health [3]. MS patients report their 
Health-Related Quality of Life (HRQoL) as worse compared with the 
general population in both the physical (PCS) and the mental (MCS) 
domains [4]. 
MS patients differ from the general population in several ways, the 
level of self-esteem, lower in MS patients, being one of them [5]. Self-
esteem is a result of a personal self-view, the assessment of oneself, and it 
is prone to changes over time [6]. The diagnosis of a chronic disease might 
be a driver of change in self-esteem [7]. The level of self-esteem is also 
associated with other concepts shaping HRQoL, such as depression, with 
evidence supporting the vulnerability model of their association in which 
low self-esteem contributes to depression [8], or with anxiety which also 
shows an association with low self-esteem [9].
Social participation is another concept associated with self-esteem 
[10,11], and satisfactory social participation is important for HRQoL in 
various health conditions [12,13]. Social participation is responsive to 
health impairments and limitations arising in physical activity over time, 
along with environmental and personal factors [14]. It is also closely 
intertwined with HRQoL, and engagement with various activities of the 
social community, friendships or work is perceived as helpful and health 
persevering [15].  
The aim of this study is to explore whether self-esteem and social 
participation are associated with the physical and mental domains of 
quality of life and whether self-esteem, as a variable that has the potential 
to be altered by intervention and health educational programs, can 
mediate the association between social participation and HRQoL.
Methods
Participants
Patients meeting the McDonald criteria were asked to participate in the 
study [16]. Out of 155 consecutive MS patients from the Department of 
Neurology of the Louis Pasteur University Hospital in Košice, 37 refused 
to participate in the study (response rate 76.1%). Exclusion criteria 
were applied to the rest of the sample. These were as follows: presence 
of a psychiatric diagnosis in the medical record, the Mini-Mental State 
Examination (MMSE) <24, pregnancy and the inability to speak Slovak. 
The final sample (N=118) consisted of 72.2% women, with a median age 
of 41.5 years (range 18-61 years). There were no statistically significant 
differences between respondents and non-respondents in terms of gender 
or age.
Procedure
This cross-sectional study consisted of a semi-structured interview, self-
reported questionnaires and a neurological examination. The invitation 
letter, the written informed consent form, the non-response sheet and 
the questionnaires were sent to participants’ homes by postal mail. After 
two weeks, patients were reminded about the questionnaire by a phone 
call. During this phone call, the interview and neurological examination 
were arranged as well. The same neurologist carried out the neurological 
examinations on all patients and a trained interviewer conducted 
the semi-structured interview, acquiring information on age, gender 
and education among other variables. Examinations took place at the 
Neurology Outpatient Clinic. 
The local Ethics Committee approved the study before it started. 
Each patient provided a signed informed consent to participate prior to 
the study. 
Measures
Sociodemographic and clinical variables
Sociodemographic variables were retrieved during interview, including 
information on age, gender and education (elementary, secondary, 
university). Clinical variables were retrieved from medical records, 
including disease duration (in years), EDSS (score ranges from 0.0 to 10.0 
with a higher score indicating more severe disability) and type of MS. 
Self-esteem
The self-esteem of patients was measured by the Rosenberg Self-Esteem 
scale (RSE) [17]. It consists of 10 items assessing global self-esteem [18]. 
Examples of items include: “On the whole, I am satisfied with myself”, or 
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“At times I think I am no good at all”. Five items are worded negatively 
and 5 positively, which then were recoded. The score ranges from 10 to 
40 with a higher number indicating a higher level of self-esteem. In our 
study self-esteem was treated as a continuous variable. Cronbach’s alpha 
for RSE in our sample was 0.87.
Social Participation
This variable was measured using the Participation scale (P-scale). 
It includes 18 items and its use is intended for people in stigmatised 
conditions [19]. Each item includes two questions. The first question goes 
into some aspect of social participation in comparison with one’s peers, 
for example: ”Do you take part in as many casual recreational/social 
activities as your peers?” If participants answer “Yes” or “Irrelevant\I 
don’t want to, I don’t have to” their answer is scored 0. If the answer is 
“Sometimes” or “No”, the next question is: “How big a problem is this 
for you?” Participants then choose from four options: “No problem”, 
“Small”, “Medium” or “Large”, which are scored 1, 2, 3 or 5, respectively. 
The summary score can range from 0 to 90; with a higher score indicating 
more restriction in social participation. Based on the score, the authors 
sort respondents into five categories of restrictions in social participation: 
No restrictions, Mild restrictions, Moderate restrictions, Severe restrictions 
and Extreme restrictions [19]. We treated participation as a continuous 
variable. Cronbach’s alpha for the P-scale in our sample was 0.89.
Health-related Quality of Life (HRQoL)
HRQoL was assessed using the 36-item Short-Form (SF-36) health survey 
[20]. The SF-36 includes multiple items to measure 8 scales: 1) physical 
functioning (ten items); 2) role limitation due to physical health (four 
items); 3) bodily pain (two items); 4) social functioning (two items); 5) 
general mental health (five items); 6) psychological distress and well-
being (five items); 7) role limitations due to emotional problems (three 
items); and 8) vitality, energy or fatigue (four items). The questionnaire 
additionally includes one question which covers changes in health status 
over the past year. All item scores are coded and transformed into a 
scale ranging from 0 (poor health) to 100 (optimal health). The Physical 
Component Summary (PCS) and the Mental Component Summary (MCS) 
were calculated. The component summary scores are normalized to a 
general population mean of 50 and a standard deviation of 10. A higher 
score indicates better HRQoL in both dimensions. Cronbach´s alpha was 
0.92 for the PCS and 0.93 for the MCS. 
Statistical analyses
Descriptive analyses of the study variables were carried out first, followed 
by linear regression analysis (the enter method), which examined the 
variance of the dependent variables (PCS, MCS) explained by studied 
variables and controlled for sociodemographic and clinical variables. 
Next, the mediating effect of self-esteem on the association between social 
participation and HRQoL was examined by structural equation modeling, 
controlled for sociodemographic and clinical variables. Statistical analyses 
were performed in IBM SPSS 20 and Mplus 7.1.
results
A basic description of the study population is given in Table 7.1 (N=118). 
The median age of the MS respondents was 40.5 years and the sample 
consisted of 72.2% women. The median EDSS score was 3, and median 
disease duration was 6 years. The majority of the patients (70.3%) 
belonged to relapse-remitting clinical course (Table 7.1).
 
Table 7.1 Description of the study population (N=118)
90	  
	  
A	  basic	   description	   of	   the	   study	   population	   is	   given	   in	   Table	   7.1	   (N=118).	   The	  median	   age	   of	   the	  MS	  
respondents	  was	  40.5	  years	  and	  the	  sample	  consisted	  of	  72.2%	  women.	  The	  median	  EDSS	  score	  was	  3,	  
and	  median	   disease	   duration	  was	   6	   years.	   The	  majority	   of	   the	   patients	   (70.3%)	   belonged	   to	   relapse-­‐
remitting	  clinical	  course	  (Table	  7.1).	  
	  	  
Table	  7.1	  Description	  of	  the	  study	  population	  (N=118)	  
Variables	   N	  (%)	   Median	   95%	  CI	   Range	  
Age	  (years)	   	   40.5	   37-­‐43	   18-­‐61	  
Gender	   	   	   	   	  
	  	  	  male	   34(28.8%)	   	   	   	  
	  	  	  female	   84(72.2%)	   	   	   	  
Education	   	   	   	   	  
	  	  	  elementary	   6(5.1%)	   	   	   	  
	  	  	  secondary	   86(72.9%)	   	   	   	  
	  	  	  university	   26(22.0%)	   	   	   	  
Disease	  duration	  
(years)	  
	   6	   5-­‐8	   1-­‐28	  
MS	  course	   	   	   	   	  
	  	  	  CIS	   14(13.9%)	   	  	  	  	  	   	   	  
	  	  	  RRMS	   71(70.3%)	   	   	   	  
	  	  	  SPMS	   16(15.8%)	   	   	   	  
EDSS	   	   3	   2.5-­‐3.5	   1.0-­‐7.0	  
RSE	   	   29	   27-­‐30	   18-­‐49	  
Participation	   	   16	   9-­‐22	   0-­‐60	  
Quality	  of	  life	  	   	   	   	   	  
	  	  	  PCS	   	   38.1	   33.7-­‐41.6	   18.5-­‐60.0	  
	  	  	  MCS	   	   43.1	   38.4-­‐48.0	   18.8-­‐67.2	  
CIS	  –	  Clinically	  Isolated	  Syndrome;	  RRMS	  –	  Relapse-­‐Remitting	  Multiple	  Sclerosis;	  SPMS	  –	  Simple	  Progressive	  Multiple	  Sclerosis;	  
EDSS	  –	  Expanded	  Disability	  Status	  Scale;	  PCS	  –	  Physical	  Component	  Summary;	  MCS	  –	  Mental	  Component	  Summary;	  CI	  –	  
Confidence	  Intervals	  
Missing	  values:	  EDSS:	  (12.7%),	  Disease	  duration:	  (4.2%),	  MS	  course:	  (14.4%),	  	  
	  
After	   having	   described	   the	   study	   sample,	   we	   proceeded	   with	   multiple	   linear	   regressions	   (the	   enter	  
method)	   for	   both	   dimensions	   of	   HRQoL,	   PCS	   and	   MCS.	   Results	   of	   these	   analyses	   showed	   that	   age,	  
CIS – Clinically Isolated Syndrome; rrMS – relapse-remitting Multiple Sclerosis; SPMS – 
Simple Progressive Multiple Sclerosis; eDSS – expanded Disability Status Scale; PCS – Physical 
Component Summary; MCS – Mental Component Summary; CI – Confidence Intervals
Missing values: eDSS: (12.7%), Disease duration: (4.2%), MS course: (14.4%)
After having described the study sample, we proceeded with multiple 
linear regressions (the enter method) for both dimensions of HRQoL, PCS 
and MCS. Results of these analyses showed that age, disease duration, 
EDSS and participation explained a significant amount of the total 
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variance in PCS, while in MCS only in EDSS and self-esteem were found 
to be significant in the final model (Table 7.2).
 
Table 7.2 Multiple linear regression (the enter method) between self-esteem, social participation 




disease	   duration,	   EDSS	   and	   participation	   explained	   a	   significant	   amount	   of	   the	   total	   variance	   in	   PCS,	  
while	  in	  MCS	  only	  in	  EDSS	  and	  self-­‐esteem	  were	  found	  to	  be	  significant	  in	  the	  final	  model	  (Table	  7.2).	  
	  	  
Table	  7.2	  Multiple	  linear	  regression	  (the	  enter	  method)	  between	  self-­‐esteem,	  social	  participation	  and	  
the	  PCS	  and	  MCS	  dimensions	  of	   the	   SF-­‐36,	   controlled	   for	   age,	   gender,	   education,	   EDSS	  and	  disease	  
duration	  
	  
PCS	   MCS	  
Beta	   F	  change	  
%	  of	  explained	  
variance	  
Beta	   F	  change	  
%	  of	  explained	  
variance	  
Model	  1	   	   8.209*	   19.8%	   	   0.559	   1.5%	  
Age	   -­‐0.453*	   	   	   -­‐0.007	   	   	  
Gender	   -­‐0.022	   	   	   0.033	   	   	  
Elementary	  
education	  
-­‐0.046	   	   	   -­‐0.045	   	   	  
Secondary	  
education	  
-­‐0.115	   	   	   -­‐0.149	   	   	  
Model	  2	   	   14.130*	   43.8%	   	   1.021	   0.1%	  
Age	   -­‐0.295*	   	   	   -­‐0.096	   	   	  
Gender	   0.043	   	   	   0.022	   	   	  
Elementary	  
education	  
-­‐0.065	   	   	   -­‐0.123	   	   	  
Secondary	  
education	  
-­‐0.039	   	   	   -­‐0.190	   	   	  
Disease	  
duration	  
0.097	   	   	   -­‐0.135	   	   	  
EDSS	   -­‐0.556*	   	   	   0.171	   	   	  
Model	  3	   	   13.651*	   46.7%	   	   14.803*	   48.9%	  
Age	   -­‐0.304*	   	   	   -­‐0.130	   	   	  
Gender	   0.040	   	   	   0.009	   	   	  
Elementary	  
education	  
-­‐0.071	   	   	   -­‐0.144	   	   	  
Secondary	  
education	  
-­‐0.020	   	   	   -­‐0.120	   	   	  
Disease	  
duration	  
0.126	   	   	   -­‐0.027	   	   	  
EDSS	   -­‐0.548*	   	   	   0.199*	   	   	  
RSE	   0.185*	   	   	   0.698*	   	   	  
Model	  4	   	   16.685*	   55.4%	   	   12.815*	   48.3%	  
Age	   -­‐0.264*	   	   	   -­‐0.129	   	   	  
Gender	   0.029	   	   	   0.009	   	   	  
Elementary	  
education	  
0.015	   	   	   -­‐0.143	   	   	  






0.166*	   	   	   -­‐0.026	   	   	  
EDSS	   -­‐0.453*	   	   	   0.199*	   	   	  
RSE	   0.031	   	   	   0.696*	   	   	  
P-­‐scale	   -­‐0.378*	   	   	   -­‐0.003	   	   	  
PCS-­‐Physical	  Component	  Summary;	  MCS-­‐Mental	  Component	  Summary;	  EDSS-­‐Expanded	  Disability	  Status	  Scale;	  RSE-­‐Rosenberg	  
Self-­‐esteem	  Scale;	  P-­‐scale-­‐Participation	  Scale;	  *p<0.05	  
	  
Finally,	  to	  assess	  the	  effect	  of	  self-­‐esteem	  on	  the	  association	  between	  participation	  and	  both	  dimensions	  
of	   HRQoL	   we	   used	   structural	   equation	   modelling.	   Results	   showed	   that	   in	   PCS	   no	   mediation	   by	   self-­‐
esteem	  was	  present	  and	  that	  only	  a	  direct	  association	  between	  participation	  and	  PCS	  was	  significant.	  In	  
the	  second	  model,	  however,	  self-­‐esteem	  showed	  full	  mediation	  and	  had	  a	  statistically	  significant	  indirect	  
effect	  on	  the	  association	  between	  participation	  and	  MCS	  (Table	  7.3).	  
	  	  
Table	  7.3	  Total,	  indirect	  (mediation	  by	  self-­‐esteem)	  and	  direct	  effects	  of	  the	  studied	  models	  
	  
PCS	   MCS	  
Estimate	   S.E.	   Est./S.E.	   Sig.	   Estimate	   S.E.	   Est./S.E.	   Sig.	  
Total	   -­‐0.387	   0.072	   -­‐5.406	   0.000	   -­‐0.316	   0.096	   -­‐3.291	   0.001	  
Specific	  
indirect	  
-­‐0.013	   0.033	   -­‐0.407	   0.684	   -­‐0.313	   0.064	   -­‐4.872	   0.000	  
Direct	   -­‐0.373	   0.081	   -­‐4.594	   0.000	   -­‐0.003	   0.088	   -­‐0.033	   0.974	  
PCS-­‐Physical	  Component	  Summary;	  MCS-­‐Mental	  Component	  Summary	  	  
	  
These	  mediations	   were	   controlled	   by	   sociodemographic	   and	   clinical	   variables.	   Beta	   coefficients	   were	  
statistically	  significant	  for	  age,	  disease	  duration	  and	  EDSS	  in	  PCS	  (Figure	  7.1).	  In	  MCS,	  mediation	  of	  study	  
variables	  by	  self-­‐esteem	  was	  present.	  The	  beta	  coefficient	  was	  significant	  only	   in	  case	  of	  EDSS	   (Figure	  
7.2)	  
	  	  
	   	  
PCS-Physical Component Summary; MCS-Mental Component Summary; eDSS-expanded 
Disability Status Scale; rSe-rosenberg Self-esteem Scale; P-scale-Participation Scale; *p<0.05
Finally, to assess the effect of self-esteem on e association between 
participation and both dimensions of HRQoL we used structural equation 
modelling. Results showed that in PCS no mediation by self-esteem was 
present and that only a direct association between participation and 
PCS was significant. In the second model, however, self-esteem showed 
full mediation and had a statistically significant indirect effect on the 
association between participation and MCS (Table 7.3).
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Self-­‐esteem	  Scale;	  P-­‐scale-­‐Participation	  Scale;	  *p<0.05	  
	  
Finally,	  to	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  the	  effect	  of	  self-­‐esteem	  on	  the	  association	  between	  participation	  and	  both	  dimensions	  
of	   HRQoL	   we	   used	   structural	   equation	   modelling.	   Results	   showed	   that	   in	   PCS	   no	   mediation	   by	   self-­‐
esteem	  was	  present	  and	  that	  only	  a	  direct	  association	  between	  participation	  and	  PCS	  was	  significant.	  In	  
the	  second	  model,	  however,	  self-­‐esteem	  showed	  full	  mediation	  and	  had	  a	  statistically	  significant	  indirect	  
effect	  on	  the	  association	  between	  participation	  and	  MCS	  (Table	  7.3).	  
	  	  
Table	  7.3	  Total,	  in ir ct	  ( ediation	  by	  self-­‐esteem)	  and	  direct	  effects	  of	  the	  studied	  models	  
	  
PCS	   MCS	  
Estimate	   S.E.	   Est./S.E.	   Sig.	   Estimate	   S.E.	   Est./S.E.	   Sig.	  
Total	   -­‐0.387	   0.072	   -­‐5.406	   0.000	   -­‐0.316	   0.096	   -­‐3.291	   0.001	  
Specific	  
indirect	  
-­‐0.013	   0.033	   -­‐0.407	   0.684	   -­‐0.313	   0.064	   -­‐4.872	   0.000	  
Direct	   -­‐0.373	   0.081	   -­‐4.594	   0.000	   -­‐0.003	   0.088	   -­‐0.033	   0.974	  
PCS-­‐Physical	  Component	  Summary;	  MCS-­‐Mental	  Component	  Summary	  	  
	  
These	  mediations	   were	   controlled	   by	   sociodemographic	   and	   clinical	   variables.	   Beta	   coefficients	   were	  
statistically	  significant	  for	  age,	  disease	  duration	  and	  EDSS	  in	  PCS	  (Figure	  7.1).	  In	  MCS,	  mediation	  of	  study	  
variables	  by	  self-­‐esteem	  was	  present.	  The	  beta	  coefficient	  was	  significant	  only	   in	  case	  of	  EDSS	   (Figure	  
7.2)	  
	  	  
	   	  
PCS-Physical Component Summary; MCS-Mental Component Summary 
These mediations were controlled by sociodemographic and clinical 
variables. Beta coefficients were statistically significant for age, disease 
duration and EDSS in PCS (Figure 7.1). In MCS, mediation of study 
variables by self-esteem was present. The beta coefficient was significant 
only in case of EDSS (Figure 7.2).
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Figure 7.1 Mediation of self-esteem on the association between participation and PCS controlled 
for sociodemographic and clinical variables
PCS-Physical Component Summary, edu- education, eDSS-expanded Disability Status Scale, 
*p<0.05
Figure 7.2 Mediation of self-esteem on the association between participation and MCS controlled 
for sociodemographic and clinical variables
MCS – Mental Component Summary, edu- education,  eDSS-expanded Disability Status Scale, 
*p<0.05
Discussion
The aim of this study was to explore whether self-esteem and social 
participation are associated with the physical and mental domains of 
quality of life and whether self-esteem can mediate the association 
between social participation and HRQoL.
The association between social participation and PCS did not seem 
to be mediated by self-esteem. The final model in the linear regression 
showed that age, disease duration, EDSS and participation are significantly 
associated with PCS, explaining 55.4% of its total variance in the model. 
The reason for this result may be the very physical nature of the variables. 
Age and disease duration are closely associated with deterioration over 
time and with more symptoms as the disease progresses [21]. EDSS as a 
measure of functional disability has always been very strongly associated 
with PCS [22]. Social participation to our knowledge has not been studied 
in this context before, although partial aspects of social life were examined 
before [23-26] and also in association with barriers that can prevent 
participation in certain activities [27]. This is also a possible explanation 
as to why social participation is statistically significant in explaining PCS 
and not MCS. Participation in social life is dependent on the objective 
ability to physically meet with people. Patients cannot participate if their 
health status prevents it. On the other hand, the recent expansion of social 
networking can possibly allow higher social participation even for people 
with more severe disabilities.
In MCS, self-esteem, along with EDSS, explained 48.3% of the total 
variance in our model and also fully mediated the association between 
participation and MCS. Self-esteem thus seems to be important in MCS, 
which is in line with previous findings in other chronic conditions [28-
30]. Being an integral part of how people see themselves, perceive their 
self-worth and interact with others, self-esteem has an important role in 
mental well-being and MCS.
Strengths and limitations
Strengths of this study include a relatively high response rate (76.1%), 
the consecutive way of collecting data as well as the complex modelling 
of variable interactions. Some limitations should be noted, however. The 
women-to-men ratio in MS is 2:1 (in our sample 72.2% women); our results 
may better explain relationship between studied variables of women than 
men. Another limitation is that patients with a lower disease severity 
(mean EDSS 3.2) were more likely to participate in the study than patients 
with a higher disability, who were more likely to refuse to participate. In 
addition, due to the cross-sectional design any causal relationships drawn 
from our results should be interpreted with caution, despite the complex 
statistical approach we used.
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Implications
Various ways of improving self-esteem can be applied for the benefit of 
MCS. It can be modified, for example, by social support and physical 
activity [31]. Social support has been found to have a protective effect 
from various adverse effects on MCS [32], so encouraging and education 
of caregivers and relatives about positive social support for self-esteem 
is important. Physical activity is another protective factor of self-
esteem, not only in terms of affecting the weight of patients, but also for 
neurochemical processes and leisure-time management [33,34]. These 
activities have high potential to bring results, as self-esteem seems to be 
very responsive to educational programs and can be improved [35]; thus 
educating patients, their caregivers, relatives and physicians about this 
topic can help improve patient self-esteem. Also, encouraging MS patients 
to engage in social participation can possibly be helpful, since we found 
an association with PCS.
Such information can also be used in MS clubs, where seminars 
and educational lectures can help patients to increase their self-esteem 
and social participation. Psychotherapists working with MS patients can 
also use these data in their work and focus on increasing the level of self-
esteem in order to improve MCS.  Future research is needed, however, 
especially longitudinal studies which would give us more information 
about the causality of the associations between the studied variables.
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Chapter 8
General discussion, implications 
and conclusions
This thesis focuses on psychological and social variables in people with 
multiple sclerosis (MS) in regard with their health-related quality of life 
(HRQoL). The individual topics were formulated as specific research 
questions and addressed in chapters 3-7. The general discussion firstly 
provides a brief overview of the main findings (8.1) and the next part 
brings about discussion of these findings (8.2). The following part 
addresses strengths and limitations of this thesis (8.3). Implications of the 
study along with possibilities for future research are summarized in the 
last part (8.4).
8.1 Main findings
Research question 1 (Chapter 3)
Are different coping strategies associated with different levels of health related 
quality of life? 
We found that all three studied types of coping (problem-focused coping, 
emotion-focused coping and coping focused on stopping unpleasant 
emotions and thoughts) were positively associated with the Mental 
Component Summary (MCS) of Health-Related Quality of Life (HRQoL), 
but were not associated with the Physical Component Summary (PCS) 
of HRQoL. In PCS significant associations were found with physical 
disability, as measured by the Expanded Disability Status Scale (EDSS) 
and disease duration. While all three coping strategies showed significant 
associations with MCS, coping focused on stopping unpleasant emotions 
and thoughts explained most of the variance in our model of linear 
regression analyses, suggesting the relative strength of this type of coping. 
Research question 2 (Chapter 4) 
Is social participation associated with the physical and mental components of 
quality of life? 
We found that there is a positive association between social participation 
and PCS along with functional disability measured by the Expanded 
Disability Status Scale (EDSS) and disease duration. These variables were 
also significant in explaining most of the variance in the PCS model. A 
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significant association between social participation and MCS was found 
as well, but the statistical model as a whole was not significant. Neither 
sociodemographic variables, nor clinical variables seemed to be associated 
with MCS either. 
Research question 3 (Chapter 5)
Do different coping strategies mediate the association between fatigue and health-
related quality of life? 
In PCS, different coping strategies showed different results. Problem-
focused coping and emotion-focused coping significantly mediated the 
association between general fatigue (GF) and HRQoL. Coping focused on 
stopping unpleasant emotions and thoughts showed a significant indirect 
effect in case of GF, physical fatigue (PF) and reduced motivation (RM). 
Reduced activity (RA) and mental fatigue (MF) were not mediated by any 
of the studied coping strategies. In MCS the mediations were presented for 
each fatigue form and every coping strategy. The highest indirect effects 
overall were found in coping focused on stopping unpleasant emotions 
and thoughts. 
Research question 4 (Chapter 6)
Do different coping strategies mediate the association between Type D personality 
and health related quality of life? 
It was found that in PCS coping did not mediate the association between 
Type D personality and HRQoL.  The direct effect of Type D personality 
on PCS was strong and coping was not associated with their interaction. 
In MCS, however, all three coping strategies mediated the association 
between Type D and HRQoL. The highest indirect effect (45%) was found 
in coping focused on stopping unpleasant emotions and thoughts. 
Research question 5 (Chapter 7)
What is the effect of self-esteem on the association between social participation 
and health related quality of life? 
Self-esteem did not mediate the association between social participation 
and PCS; only the direct association between these two variables is 
significant. Self-esteem on the other hand mediated the association 
between social participation and MCS.
8.2 Discussion of the main findings
This thesis focused on factors associated with health related quality of life 
(HRQoL) in patients with MS. Our main points of interest were variables 
of coping, social participation and self-esteem and their associations with 
PCS and MCS. Our study is also partially inspired by the ICF model 
where social participation plays important role associated with disability. 
This model also stresses the existence of interactive associations between 
various factors which is beneficial in getting a more comprehensive view 
on HRQoL in patients with MS. Based on our research questions we 
derived our own theoretical model where research questions are centered 
around HRQoL as a variable we find crucial for patients with multiple 
sclerosis (MS) (Figure 8.1). Results from this thesis are summarized below 
(Table 8.1).
Figure 8.1 Design of the variables used in the study 
Table 8.1 Main results of the thesis
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8.2.1 Coping self-efficacy and quality of life in patients with multiple sclerosis
We found that the mental component of health related quality of life 
(MCS) is associated with all coping strategies and that coping self-efficacy 
is a part of the complex associations between Type D personality and 
fatigue. All three coping strategies seem to be important for MCS, not 
only in patients with multiple sclerosis (MS) but also with various other 
chronic conditions [1-4].
In our study, coping seems to have a mediating effect on a number of 
variables. Fatigue as one of the most common symptoms of MS seems to 
be mediated not only in MS but also in other chronic conditions [5,6]. The 
most explanatory of the three studied coping strategies seems to be coping 
focused on stopping unpleasant emotions and thoughts. In patients with 
MS, this coping strategy explained the most variance of all the coping 
strategies in MCS and mediated the associations of both fatigue and 
type D personality with MCS with the highest effect. No optimal cure 
for MS has been found so far [7,8] leaving patients without the ability 
to control the disease directly. With having very little control over their 
disease and its course due to its chronic nature and unpredictable set of 
symptoms [9,10], active coping strategies may not be the most efficient for 
people with MS. Stopping unpleasant emotions and thoughts can thus 
effectively reduce the stress that MS brings and improve patient’s MCS. 
This interpretation is in line with previous studies which suggest that this 
coping strategy is more adaptive when little control is possible, which is 
true for the situation of MS patients [11,12].
On the other hand, our results showed that regarding PCS, the role 
of coping was not significant or at least not significant as on the level of 
MCS. For the most part functional disability measured by the expanded 
disability status scale (EDSS) was the main predictor of PCS. This result 
is in line with existing studies dealing with coping and quality of life 
[13,14], although in some other diseases, this association seems to be 
significant [15,16]. The reason why PCS was not prominently associated 
with any type of coping might be due to the fact that residual persisting 
neurological symptoms cannot be suppressed by coping strategies. 
Adverse inflammatory processes take place in the brain tissue even if 
patients use coping strategies effectively [17]. Thus, PCS might be only 
marginally modified by a psychological resource such as coping.
Some studies focused also on quality of life of caregivers who live 
in the same household with the MS patient, but they did not come up 
with similar results. Especially coping focused on getting support showed 
a negative association with quality of life in caregivers [18]. Caregivers, 
although forced to adapt to symptoms of MS in their household, may not 
experience same feelings as people they are taking care of [19].
8.2.2 Social participation, self-esteem and quality of life in patients with 
multiple sclerosis
Findings from our study indicate that social participation is associated 
with PCS but not with MCS. Although the beta coefficient of social 
participation suggests some weak association with MCS, the overall 
model is not significant and in chapter 7 social participation shows a 
significant association with PCS only. Furthermore we found that self-
esteem on the other hand does not seem to be associated with PCS, but is 
associated with MCS. This finding is in line with an earlier study [20]. The 
rationale for these findings may be in the physical nature of MS [21,22]. 
Participation in social life is based on the ability to go, move, transport 
and physically meet with other people. Movement may be very limited 
in later stages of MS [23-25] and thus preventing the positive effect of 
social participation in building and maintaining friendships, being part of 
community whether it is work, religious or hobby oriented or engaging in 
culture experiences. Self-esteem, although also important in social life [26], 
is a very subjective and internal variable and thus may not be dependent 
on physical ability [27]. In our findings self-esteem is associated with MCS 
and it also mediates the association between social participation and MCS, 
indicating that self-esteem can have a positive impact on these variables.
8.3 Strengths and limitations of the study
One of the strengths of this study is the high response rate within our 
sample (72.9%). The approach regarding social participation on the basis 
of peer comparisons in relation to HRQoL is also a strength of this study, 
as it gives us a better understanding of social participation in the specific 
condition of a chronic disease and not only a comparison with the general 
average population. The consecutive method of collecting data and the 
complex modelling of variable interactions also belong among the strong 
points of this study.
Some limitations should be noted, however. Although the women-to-
men ratio in MS is 2:1, in our sample the ratio was higher (75.0% women), 
so the results may better explain the quality of life of women more so than 
men. Also, patients with a lower disease severity (mean EDSS 3.2) were 
more likely to participate in the study, while patients with a more serious 
disability were more likely to refuse to participate. Regarding personality, 
we used Type D, and in the case of coping we used coping self-efficacy, so 
our findings should be generalised with caution to personality or coping 
measured in different ways. In addition, due to the cross-sectional design 
any causal relationships drawn from our results should be interpreted 
with caution.
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8.4 Implications
8.4.1 Implications for clinical practice
This thesis is beneficial in bringing a new view on avoidance coping. 
Stopping unpleasant emotions and thoughts showed in our results to be 
an adaptive and helpful characteristic for patients with MS. Although 
this type of coping may seem to be maladaptive, in our sample it helped 
to improve the mental component of quality of life. It also showed 
significant effects in the mediating associations between coping, fatigue 
and MCS and between coping, Type D and MCS with the highest levels 
of statistical significance from the three studied coping strategies. The 
clinical importance of this study is that MS patients should consider using 
this type of coping in dealing with their condition. Physicians, caregivers, 
psychologists, psychotherapists and patients themselves should be 
educated about various ways of coping with their disease and encouraged 
to live a life without constant worries about their symptoms or the progress 
of their disease and thus improve their MCS. Another part of education 
of patients, caregivers and all professionals taking interest in patient with 
MS can focus on reducing the effect of coping on the association between 
fatigue and PCS but especially MCS, where coping may act as a protective 
factor. Similar recommendations can be stated for type D personality 
and although we believe that type D personality traits are fairly stable, 
coping strategies can actively be modified and possibly bear an effect 
on depressive and anxiety related symptoms associated with negative 
affectivity and social inhibition of type D personality and thus be of great 
use in diminishing the adverse effects of type D on MCS. MS clubs could 
apply these outcomes during discussions/educational programs with MS 
patients, where psychologists or trained caregivers could talk with patients 
about the various ways of coping with their disease. Physicians could also 
benefit from the knowledge about different ways of coping with stress, 
especially in the early stages of the disease when patients are still learning 
how to live with a new diagnosis of MS. Even patients with longer disease 
duration could make use of these findings if their coping strategies have so 
far proved to be ineffective. These findings can also be implemented into 
the psychological therapy process. Cognitive Behavioural Therapy (CBT) 
may work with stopping unpleasant emotions and thoughts in patients 
with MS [28]. Various forms of treatment working with techniques that 
can diminish the effect of fatigue in patients with chronic conditions 
[29,30], either in long individual therapies or education about the role of 
coping, can be included in shorter pragmatic programs too [31].
This study is also beneficial in that it shows that social participation is 
very important for PCS in MS patients. According to our results, isolation 
and avoiding social activities are associated with lower HRQoL in patients 
with MS. Hiding from social activities may seem comfortable and easy as it 
eliminates the stress from obstacles in social participation caused by health 
problems, but this study indicates that people who don’t engage in social 
participation have a worse PCS. Additionally various ways of improving 
self-esteem can be applied for the benefit of MCS. It can be modified, 
for example, by social support aforementioned social participation and 
physical activity [32]. Social support has been found to have a protective 
effect from various adverse effects on MCS [33], so encouraging and 
education of caregivers and relatives about positive social support for 
self-esteem is important. Physical activity is another protective factor of 
self-esteem, not only in terms of affecting the weight of patients, but also 
for neurochemical processes and leisure-time management [34,35]. These 
activities have a high potential to bring results, as self-esteem seems to 
be very responsive to educational programs and can be improved [36]. 
Thus, patients with MS should be educated about ways in which social 
activities can benefit them and should be encouraged to engage in social 
participation even if physical obstacles make it more difficult. These 
recommendations along with the ones from research focused on coping, 
can be used together in a series of educations seminars supplemented 
by role play model situations, social games and introspective sessions in 
order to create a full fleshed unit on how to improve some of the aspects 
of HRQoL. This can also be beneficial for caretakers and physicians of 
MS patients who can benefit from education about coping with non-
treatable disease as well. They can be included in social games focused 
on social participation as well and with better understanding of MS, they 
can be more effective and understanding of various challenges it brings. 
Psychologists working with people with MS may use these results as a 
basis for therapy sessions, use them in rehabilitation of patients, training 
of daily activities or help them with changing coping strategies with 
longer disease duration and disease progression.
8.4.2 Implications for future research
Coping seems important in various associations of HRQoL with other 
variables in multiple sclerosis. Future research is needed though, to 
see if it shows similar results in other chronic conditions, along with 
control studies of healthy population and caregivers. Also longitudinal 
studies on how coping strategies change with longer disease duration, 
how social participation evolves with more symptoms and how fatigue, 
type D and self-esteem change their associations with more impairments 
caused by MS should be done in order to determine causality of studied 
associations. Similar research in other chronic conditions like Parkinson’s 
disease rheumatoid arthritis, fibromyalgia and others are also needed in 
order to generalize these results on populations with chronic diseases. 
Randomised Clinical Trial interventions along with a pilot study and 
subsequent studies of effect of educational program proposed in this 
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thesis is another point of interest for future research.
8.5 Conclusion
It was found that problem-focused coping, emotion-focused coping and 
coping focused on stopping unpleasant emotions and thoughts were all 
predictors of mental component of health related quality of life (MCS) and 
that all three coping strategies mediated the associations between fatigue 
and MCS and also between type D and MCS. We also found that self-
esteem is a predictor of MCS and mediated the association between social 
participation and MCS. Social participation by itself on the other hand 
was associated only with physical component of quality of life (PCS). 
Coping, social participation and self-esteem may thus play an important 
role in HRQoL outcomes in patients with multiple sclerosis.
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Summary
Multiple sclerosis (MS) is one of the most widespread disabling 
neurological conditions of young adults in the world. One can get MS 
at any age, but the majority of the patients are diagnosed between 
the ages of 20 and 40. Because of its onset in early adulthood, MS has 
serious consequences not only for the individual, but also for society as 
symptoms of MS may cause work inability in the most productive age 
group.  Furthermore MS affects people around the patient for a very long 
time. Symptoms of MS span from physical ones like movement problems, 
pain during walking, vertigo and problems with vision to mental ones like 
cognitive impairment, anxiety and depression. In our research we focused 
on quality of life in both the Physical Component Summary (PCS) and 
Mental Component Summary (MCS) of Health-Related Quality of Life 
(HRQoL) and associated them with factors like fatigue, type D personality 
and functional disability to further explore the complex effect of factors 
previously described in the literature like coping and social participation 
which seemed to be positively associated with HRQoL.
Chapter 1 provides a general introduction on MS and on the 
variables studied in this thesis. Further it states the aims of the thesis and 
formulates the research questions.
Chapter 2 provides information about the design of the study. It 
describes the study sample used in this thesis. Furthermore it outlines 
measures used during data collection and statistical analyses.
The aim of chapter 3 was to explore whether different coping 
strategies were associated with different levels of HRQoL. Multiple linear 
regression analyses showed that in PCS coping was not a significant 
contributor to the variance in the model however, it contributed 
significantly to the variance of MCS. Although there were no differences 
between problem-focused coping, emotion-focused coping and coping 
focused on stopping unpleasant emotions and thoughts in terms of 
significance, stopping unpleasant emotions and thoughts showed to be 
the best explanatory variable of these three coping strategies. According 
to our results we can hypothesize that coping, especially coping focused 
on stopping unpleasant emotions and thoughts is a predictor of better 
MCS, although more research among which a longitudinal confirmatory 
study is needed.
In chapter 4 we explored whether social participation is associated 
with PCS and MCS. Based on multiple linear regression analyses we 
concluded that this variable is associated with PCS, but not with MCS. 
After discussing this unexpected result regarding the previous literature 
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we hypothesized, that in people with MS social participation is closely 
related to the ability to engage in social situations, which is based on 
functional ability, so that mental resources are not prominent in this 
association. Although social participation still seems associated with PCS 
future research will shed more light on causality of this association.
The aim of chapter 5 was to determine whether coping is able to 
mediate the negative association between fatigue as most common 
symptom of MS and HRQoL. All five different forms of fatigue were 
associated with HRQoL and mediations by all three different coping 
strategies were examined, but only in MCS each combination of coping/
fatigue was statistically significant. Besides, only the association between 
general fatigue and PCS was mediated by each coping strategy. Coping 
focused on stopping unpleasant emotions and thoughts also mediated 
associations between physical fatigue and PCS and reduced motivation 
and PCS.
Chapter 6 focused on the question whether different coping 
strategies mediate the association between type D personality and 
HRQoL. Mediations by all three studied coping strategies were present in 
MCS, but not in PCS. Confronted with previous research we concluded 
that MCS is responsive to self-helping tendencies and is much more 
easily confounded by actions of individuals in such a way that even the 
association between personality - negative affectivity and social inhibition 
– and MCS can be mediated by coping.
The aim of chapter 7 was to explore the role of self-esteem regarding 
the association between social participation and HRQoL. Structural 
equation modeling analyses showed that self-esteem mediates the 
association between social participation and MCS, while the association 
between social participation and PCS showed only a direct effect and 
was not mediated by self-esteem. This result only further strengthened 
our previous hypothesis about the association between PCS and social 
participation, but also showed the importance of self-esteem for MCS.
Finally, in chapter 8 we summarized all findings, discussed them 
in the context of existing knowledge and our theoretical framework and 
discussed implications. Generally, we found that all coping strategies 
are positively associated with MCS, but not with PCS and although 
coping focused on stopping unpleasant emotions and thoughts may 
not be most appropriate for the general population, in our sample of 
people with MS it proved as valuable as other studied coping strategies 
with showing statistically significant results on more than one occasion. 
Self-esteem also showed a promising association with MCS and thus 
focusing on coping and self-esteem may have positive impact on MCS. 
Social participation was on the other hand associated with PCS only and 
although the causality of this association is not yet clear, encouraging 
social participation in patients with MS may have positive impact on their 
PCS. Chapter 8 also addresses the strengths and limitations of the study. 
Strengths include high response rate, peer comparisons regarding social 
participation, consecutive way of collecting data and complex statistical 
modelling. Limitations consist of a higher women-to-men ratio as in the 
general MS population and more patients with lower disease severity. 
The last chapter also includes implications for clinical practice which 
emphasize role of coping focused on stopping unpleasant emotions and 
thought for HRQoL, highlight the impact of self-esteem and propose 
educational programs for patients and caregivers. Future research should 
be focused on longitudinal confirmations of these results, on replicating 
the study design on other chronic conditions and a study of the effect of 




Multipele sclerose (MS) is één van de meest voorkomende invaliderende 
neurologische aandoeningen van jong volwassenen. MS kan men 
krijgen op elke leeftijd, maar de meerderheid van de patiënten wordt 
gediagnosticeerd op de leeftijd tussen 20 en 40 jaar. Vanwege het begin 
ervan in de vroege volwassenheid heeft MS ernstige gevolgen, niet 
alleen voor het individu, maar ook voor de samenleving, omdat MS 
ernstige beperkingen en arbeidsongeschiktheid kan veroorzaken in de 
meest productieve leeftijdsgroep. Verder treft MS mensen rondom de 
patiënt, vaak voor een zeer lange tijd. De symptomen van MS betreffen 
fysieke problemen, zoals bewegingsproblemen, pijn tijdens het lopen, 
duizeligheid en problemen met de visus, als ook mentale problemen 
zoals cognitieve stoornissen, angst en depressie. In ons onderzoek hebben 
we ons gericht op de beide onderdelen van kwaliteit van leven, zowel 
de fysieke component (PCS) als de mentale component (MCS) van de 
gezondheids-gerelateerde kwaliteit van leven (GGKvL). We exploreerden 
hun verband met factoren zoals vermoeidheid, type D persoonlijkheid en 
functionele invaliditeit en daarnaast het verband met factoren die eerder 
beschreven zijn in de literatuur zoals coping en sociale participatie, die 
een positief verband met GGKvL lijken te hebben.
In Hoofdstuk 1 wordt een algemene inleiding over MS gegeven 
en over de variabelen die in dit proefschrift worden onderzocht. Verder 
worden de doelstellingen van het proefschrift weergegeven en de 
onderzoeksvragen geformuleerd.
In Hoofdstuk 2 wordt informatie gegeven over de opzet van het 
onderzoek. Beschreven wordt de steekproef die in dit proefschrift wordt 
gebruikt. Verder worden de meetinstrumenten geschetst die zijn gebruikt 
bij het verzamelen van gegevens en de statistische analyses.
Het doel van Hoofdstuk 3 is om te onderzoeken of verschillende 
coping-strategieën verband hielden met verschillende niveaus van 
GGKvL. Meervoudige lineaire regressie-analyses lieten zien dat met 
betrekking tot PCS coping niet een significante bijdrage aan de variantie 
van het model leverde; echter coping droeg in significante mate bij aan 
de verklaarde variantie van MCS. Hoewel er geen significante verschillen 
waren tussen probleem-georiënteerd coping gedrag, emotie-georiënteerd 
coping gedrag en coping gericht op het stoppen van onaangename emoties 
en gedachten, bleek het stoppen van onaangename emoties en gedachten 
de beste verklarende variabele van deze drie strategieën te zijn. Op basis 
van deze resultaten kunnen we veronderstellen dat coping, vooral coping 
gericht op het stoppen van onaangename emoties en gedachten een 
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voorspeller is van een betere MCS, hoewel meer onderzoek, waaronder 
longitudinaal confirmatief onderzoek nodig is.
In hoofdstuk 4 hebben we onderzocht of sociale participatie 
samenhangt met PCS en MCS. Op basis van meervoudige lineaire regressie 
analyses hebben we geconcludeerd dat deze variabele samenhangt met 
PCS, maar niet met MCS. Dit onverwachte resultaat dat niet in lijn is met 
de bestaande literatuur doet ons veronderstellen we dat bij MS sociale 
participatie nauw verweven is met iemands functionele mogelijkheden, 
met een minder prominente rol van mentale hulpbronnen. Hoewel sociale 
participatie samen lijkt te hangen met PCS moet toekomstig onderzoek 
meer licht werpen op de causaliteit van dit verband.
Het doel van hoofdstuk 5 is te bepalen of coping de negatieve 
samenhang tussen vermoeidheid als meest voorkomend symptoom van 
MS en GGKvL kan mediëren. Er bestond een statistisch significand verband 
tussen alle vijf verschillende vormen van vermoeidheid en GGKvL; 
daarna werd het mediëren door de drie verschillende coping strategieën 
onderzocht, maar alleen in het geval van MCS was elke combinatie van 
coping / vermoeidheid statistisch significant. Alleen het verband tussen 
algemene vermoeidheid en PCS werd gemedieerd door elke vorm van 
coping. Alleen coping gericht op het stoppen van onaangename emoties 
en gedachten medieerde ook de verbanden tussen fysieke vermoeidheid 
en PCS en verminderde motivatie en PCS.
Hoofdstuk 6 richt zich op de vraag of de verschillende coping-
strategieën het verband tussen type D persoonlijkheid en GGKvL 
mediëren. Mediëring door alle drie onderzochte coping strategieën was 
aanwezig bij MCS, maar niet bij PCS. Uit eerder onderzoek hebben we 
geconcludeerd dat MCS reageert op zelfhulp en veel gemakkelijker 
verstoord kan worden door handelingen van individuen in een mate dat 
zelfs de samenhang tussen persoonlijkheid - negatieve affectiviteit en 
sociale inhibitie - en MCS kan worden gemedieerd door coping.
Het doel van hoofdstuk 7 was om de rol die het gevoel van 
eigenwaarde speelt in de samenhang tussen sociale participatie en GGKvL 
te onderzoeken. Structural equation modeling analyses toonden aan dat 
het gevoel van eigenwaarde de samenhang tussen sociale participatie 
en MCS medieert, terwijl het verband tussen sociale participatie en PCS 
alleen een direct effect liet zien en niet werd gemedieerd door het gevoel 
van eigenwaarde. Dit resultaat versterkt onze eerdere hypothese over het 
verband tussen PCS en sociale participatie, maar toont ook het belang aan 
van het gevoel van eigenwaarde voor MCS.
Tenslotte hebben we in hoofdstuk 8 alle bevindingen samengevat en 
bediscussieerd op basis van de bestaande kennis en het theoretisch kader, 
en voorts de mogelijke implicaties daarvan. Over het algemeen vonden 
we dat alle coping strategieën positief samenhingen met MCS, maar niet 
met PCS en hoewel coping gericht op het stoppen van onaangename 
emoties en gedachten misschien niet het meest geschikt lijkt voor de 
algemene bevolking, bleek dit in onze steekproef van mensen met MS 
waardevol. Eigenwaarde toonde ook een veelbelovende samenhang met 
MCS en dus zouden interventies gericht op coping en het gevoel van 
eigenwaarde een positieve invloed op MCS kunnen hebben. Anderzijds 
bestond er tussen sociale participatie alleen een verband met PCS en 
hoewel de causaliteit van deze samenhang nog niet duidelijk is, kan het 
stimuleren van sociale participatie bij patiënten met MS een positieve 
invloed hebben op hun PCS. Hoofdstuk 8 gaat ook in op de sterke punten 
en beperkingen van het onderzoek. Sterke punten zijn de hoge respons, 
vergelijking met leeftijdsgenoten waar het gaat om sociale participatie, 
een opeenvolgende manier van het verzamelen van gegevens en het 
gebruik van complexe statistische modellen. Beperkingen zijn gelegen 
in een hogere vrouw - man verhouding dan in de algemene bevolking 
met MS en in meer patiënten met een minder ernstige ziekte. Het laatste 
hoofdstuk bevat ook implicaties voor de klinische praktijk met het focus 
op de rol van coping gericht op het stoppen van onaangename emoties en 
gedachten voor de GGKvL, de invloed van het gevoel van eigenwaarde en 
voorstellen over educatieve programma’s voor patiënten en zorgverleners. 
Toekomstig onderzoek moet zich richten op longitudinale toetsing van 
onze resultaten, op het herhalen en toepassen van ons onderzoek ontwerp 





Skleróza multiplex (SM) predstavuje jedno zo svetovo najrozšírenejších 
neurologických ochorení u mladých dospelých. SM môže byť 
diagnostikovaná v akomkoľvek veku, ale jej výskyt kumuluje prevažne 
medzi dvadsiatym a štyridsiatym rokom života. Práve kvôli skorému 
nástupu ochorenia, má MS vážne dôsledky nie len pre jedinca, ktorého 
postihne, ale aj pre jeho sociálne okolie. SM môže viesť k práceneschopnosti 
práve v najproduktívnejšej vekovej skupine a ovplyvňuje rodinný 
a partnerský život pacienta. Symptómy sprevádzajúce SM zahŕňajú 
fyzickú sféru (problémy s pohybom, bolesť počas chôdze, závraty 
a problémy so zrakom) a mentálnu oblasť (kognitívne problémy, úzkosť 
a depresiu). V rámci nášho výskumu sme sa zamerali na kvalitu života 
súvisiacu so zdravím v oboch jej komponentoch - fyzickom aj mentálnom 
(PCS, MCS) a asociovali ju s faktormi ako únava, osobnosť typu D 
a funkčná disabilita, prostredníctvom ktorých sme preskúmali komplexné 
vzťahy medzi uvedenými premennými a faktormi. Ide o aspekty, ktoré 
boli preskúmané výskumníkmi už v minulosti, napr. coping a sociálna 
participácia vykazujú pozitívnu asociáciu s kvalitou života.
Prvá kapitola ponúka všeobecný prehľad o SM a základných 
premenných skúmaných v tejto práci. Zároveň popisuje ciele práce 
a formuluje výskumné otázky.
Druhá kapitola je venovaná problematike dizajnu tejto štúdie. 
Popisuje výskumnú vzorku, metodiky použité pri zbere dát a pri 
štatistickom spracovaní údajov. 
Zámerom tretej kapitoly bolo preskúmať rôzne copingové stratégie 
a ich asociácie s rôznymi úrovňami so zdravím súvisiacej kvality 
života. Viacnásobná lineárna regresia ukázala, že v rámci PCS, coping 
nepredstavoval signifikantný príspevok k variancii v rámci PCS modelu, 
ale na druhej strane jeho príspevok bol signifikantný v prípade MCS. 
Hoci neboli nájdené rozdiely medzi copingom zameraným na riešenie 
problémov, copingom zameraným na emocionálne prežívanie a copingom 
zameraným na zastavenie nepríjemných pocitov a myšlienok v rámci 
štatistickej významnosti, zastavenie nepríjemných pocitov a myšlienok 
sa ukázalo byť typom copingu, ktorý vysvetlil najviac variancie v rámci 
modelu. Na základne našich výsledkov môžeme konštatovať, že coping (a 
najmä coping zameraný na zastavenie nepríjemných pocitov a myšlienok) 
je prediktorom lepšieho MCS. Pre potvrdenie uvedených výsledkov je 
potrebné uvažovať o realizácii longitudinálnej štúdie.
Vo štvrtej kapitole sme zisťovali súvislosť sociálnej participácie 
s PCS a MCS. Na základe analýz lineárnej regresie sme došli k záveru, 
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že táto premenná je asociovaná s PCS ale nie s MCS. Po konfrontácii 
našich výsledkov s dostupnou literatúrou sme dospeli k záveru, že u 
ľudí trpiacich SM je sociálna participácia v úzkom súvise so schopnosťou 
zapájať sa do sociálnych situácií, ktorá je závislá na fyzickej kondícii. 
Mentálne rezervy pacientov nehrajú v uvedenom vzťahu žiadnu rolu. Aj 
keď sa sociálna participácia zdá byť asociovaná s PCS, na určenie smeru 
tohto vzťahu je potrebný ďalší výskum.
Cieľom piatej kapitoly bolo určiť či je coping schopný mediovať 
negatívne asociácie medzi únavou (najčastejším symptómom 
sprevádzajúcim SM) a kvalitou života súvisiacou so zdravím. Päť rôznych 
foriem únavy bolo skúmaných vo vzťahu s kvalitou života a zároveň 
sme sledovali mediácie copingom v rámci uvedených asociácií, avšak 
iba v prípade MCS boli všetky kombinácie únavy a copingu štatisticky 
významné. V rámci PCS boli zistené asociácie medzi všeobecnou únavou 
a PCS, ktoré boli zároveň mediované každou z copingových stratégií. 
Coping zameriavajúci sa na zastavenie nepríjemných emócií a myšlienok 
medioval asociácie medzi fyzickou únavou a PCS a rovnako medzi 
redukovanou motiváciou a PCS.
Šiesta kapitola sa zameriavala na otázku či rôzne copingové stratégie 
mediujú asociácie medzi osobnosťou typu D a kvalitou života. Mediácie 
medzi všetkými troma druhmi copingu boli prítomné v rámci MCS, ale 
nie v PCS. Na základe našich zistení a predchádzajúcich štúdií v tejto 
oblasti sme došli k záveru, že MCS je schopná zrkadliť seba-pomáhajúce 
tendencie a je oveľa ľahšie ovplyvnená konkrétnymi krokmi jednotlivcov. 
Uvedené implikuje, že asociácia medzi osobnosťou typu D (vyznačujúca 
sa negatívnou afektivitou a sociálnou inhibíciou) a MCS môže byť 
mediovaná copingom.
Zámerom siedmej kapitoly bolo preskúmať rolu sebaúcty v rámci 
vzťahu sociálna participácia a kvalita života. Štatistická analýza 
štruktúrovaného modelovania ukázala, že sebaúcta je mediátorom 
asociácie medzi sociálnou participáciou a MCS, zatiaľ čo asociácia medzi 
sociálnou participáciou a PCS mala iba priamy efekt a nebola mediovaná 
sebaúctou. Tento záver potvrdil našu predchádzajúcu hypotézu o asociácii 
medzi PCS a sociálnou participáciou, ale taktiež poukázal na dôležitosť 
sebaúcty pre MCS.
Ôsma kapitola predstavuje sumár všetkých výsledkov, ktoré sme 
konfrontovali v kontexte ďalších štúdií a nášho teoretického modelu a v 
neposlednom rade pojednávane o implikáciách pre prax. Vo všeobecnosti 
sme došli k záveru, že copingové stratégie sú pozitívne asociované 
s MCS, ale nie s PCS a hoci coping zameraný na zastavenie nepríjemných 
myšlienok a pocitov nemusí byť vo všeobecnej populácii tou najvhodnejšou 
voľbou, v súbore pacientov so SM sa ukázal ako užitočný aspoň na takej 
úrovni ako iné coingové stratégie, so štatisticky významnými výsledkami 
vo viacerých prípadoch. Sebaúcta taktiež preukázala významné asociácie 
s MCS a doviedla nás k záveru, že zameriavanie sa na coping a sebaúctu 
u pacientov so SM môže viesť k veľmi pozitívnym výsledkom v rámci ich 
mentálnej kvality života. Sociálna participácia bola asociovaná prevažne 
s PCS a aj keď je smer uvedenej asociácie zatiaľ nejasný, podpora sociálnej 
participácie u pacientov trpiacich SM môže mať pozitívne dôsledky pre 
ich PCS. Ôsma kapitola sa v závere venuje popisuju silných a slabých 
stránok práce. Silné stránky zahŕňajú vysoký response rate, hodnotenie 
sociálnej participácie z pohľadu rovesníkov, spôsob zberu dát a komplexné 
štatistické modelovanie. Medzi slabé stránky môžeme zaradiť vyšší 
pomer žien vo vzorke a vyšší počet pacientov s menej vážnymi formami 
SM. Posledná kapitola zahŕňa taktiež implikácie pre klinickú prax, 
ktoré zdôrazňujú rolu copingu zameraného na zastavenie nepríjemných 
myšlienok a pocitov v rámci na zdravie zameranej kvality života, 
zdôrazňujú dopad sebaúcty a navrhujú edukačné programy pre pacientov 
a ich blízkych. Ďalší výskum by sa mal sústrediť na longitudinálne 
skúmanie našich záverov, replikovanie dizajnu tejto štúdie u iných 
chronických ochorení a v neposlednom rade na praktické  študovanie 
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